Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 31, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-14063

JABIL INC.

(Exact name of registrant as specified in its charter)


Delaware						38-1886260
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

10800 Roosevelt Boulevard North, St. Petersburg, Florida 33716

(Address of principal executive offices) (Zip Code)

(727) 577-9749

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value per share	JBL	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of July 2, 2024, there were 113,445,192 shares of the registrant’s Common Stock outstanding.

Table of Contents

JABIL INC. AND SUBSIDIARIES INDEX


Part I – Financial Information
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets as of May 31, 2024 and August 31, 2023	1
	Condensed Consolidated Statements of Operations for t he three months and nine months ended May 31, 2024 and 2023	2
	Condensed Consolidated Statements of Comprehensive Income for the three months and nine months ended May 31, 2024 and 2023	3
	Condensed Consolidated Statements of Stockholders’ Equity for the three months and nine months ended May 31, 2024 and 2023	4
	Condensed Consolidated Statements of Cash Flows for the nine months ended May 31, 2024 and 2023	5
	Notes to Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
Item 4.	Controls and Procedures	32

Part II – Other Information
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 3.	Defaults Upon Senior Securities	33
Item 4.	Mine Safety Disclosures	33
Item 5.	Other Information	33
Item 6.	Exhibits	34
	Signatures	36

Table of Contents

PART I—FINANCIAL INFORMATION


Item 1.			Financial Statements

JABIL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except for share data)


	May 31, 2024 (Unaudited)		August 31, 2023
ASSETS
Current assets:
Cash and cash equivalents	$	2,457	$	1,804
Accounts receivable, net of allowance for credit losses	3,382		3,647
Contract assets	1,121		1,035
Inventories, net of reserve for excess and obsolete inventory	4,439		5,206
Prepaid expenses and other current assets	1,494		1,109
Assets held for sale	—		1,929
Total current assets	12,893		14,730
Property, plant and equipment, net of accumulated depreciation of $4,668 as of May 31, 2024 and $4,512 as of August 31, 2023	2,963		3,137
Operating lease right-of-use asset	366		367
Goodwill	655		621
Intangible assets, net of accumulated amortization	155		142
Deferred income taxes	129		159
Other assets	288		268

Total assets	$	17,449	$	19,424
LIABILITIES AND EQUITY
Current liabilities:
Current installments of notes payable and long-term debt	$	—	$	—
Accounts payable	5,398		5,679
Accrued expenses	5,929		5,515
Current operating lease liabilities	96		104
Liabilities held for sale	—		1,397
Total current liabilities	11,423		12,695
Notes payable and long-term debt, less current installments	2,879		2,875
Other liabilities	331		319
Non-current operating lease liabilities	285		269
Income tax liabilities	112		131
Deferred income taxes	143		268

Total liabilities	15,173		16,557
Commitments and contingencies
Equity:
Jabil Inc. stockholders’ equity:
Preferred stock, $0.001 par value, authorized 10,000,000 shares; no shares issued and no shares outstanding	—		—
Common stock, $0.001 par value, authorized 500,000,000 shares; 276,079,193 and 273,949,811 shares issued and 118,720,679 and 131,294,422 shares outstanding as of May 31, 2024 and August 31, 2023, respectively	—		—
Additional paid-in capital	2,881		2,795
Retained earnings	5,632		4,412
Accumulated other comprehensive loss	(18)		(17)
Treasury stock at cost, 157,358,514 and 142,655,389 shares as of May 31, 2024 and August 31, 2023, respectively	(6,219)		(4,324)
Total Jabil Inc. stockholders’ equity	2,276		2,866
Noncontrolling interests	—		1
Total equity	2,276		2,867
Total liabilities and equity	$	17,449	$	19,424

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

JABIL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except for per share data)

(Unaudited)


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Net revenue	$	6,765	$	8,475	$	21,919	$	26,244
Cost of revenue	6,157		7,778		19,906		24,143
Gross profit	608		697		2,013		2,101
Operating expenses:
Selling, general and administrative	268		307		890		911
Research and development	9		8		29		25
Amortization of intangibles	12		7		27		24
Restructuring, severance and related charges	55		—		252		45
Gain from the divestiture of businesses	—		—		(944)		—
Acquisition and divestiture related charges	3		—		64		—
Operating income	261		375		1,695		1,096


Other expense	22		18		65		50
Interest expense, net	38		51		132		154
Income before income tax	201		306		1,498		892
Income tax expense	72		73		248		229
Net income	129		233		1,250		663
Net income attributable to noncontrolling interests, net of tax	—		—		—		—
Net income attributable to Jabil Inc.	$	129	$	233	$	1,250	$	663
Earnings per share attributable to the stockholders of Jabil Inc.:
Basic	$	1.08	$	1.76	$	10.01	$	4.96
Diluted	$	1.06	$	1.72	$	9.86	$	4.86
Weighted average shares outstanding:
Basic	119.9		132.3		124.9		133.6
Diluted	121.7		135.1		126.9		136.4

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

JABIL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

(Unaudited)


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Net income	$	129	$	233	$	1,250	$	663
Other comprehensive income (loss):
Change in foreign currency translation	1		3		(6)		21
Change in derivative instruments:
Change in fair value of derivatives	—		(13)		(4)		(20)
Adjustment for net (gains) losses realized and included in net income	(1)		(8)		13		36
Total change in derivative instruments	(1)		(21)		9		16




Actuarial loss	(2)		(3)		(7)		(8)
Prior service credit	1		1		3		2
Total other comprehensive (loss) income	(1)		(20)		(1)		31
Comprehensive income	$	128	$	213	$	1,249	$	694
Comprehensive income attributable to noncontrolling interests	—		—		—		—
Comprehensive income attributable to Jabil Inc.	$	128	$	213	$	1,249	$	694

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

JABIL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in millions)

(Unaudited)


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Total stockholders' equity, beginning balances	$	2,658	$	2,674	$	2,867	$	2,452




Common stock:	—		—		—		—
Additional paid-in capital:
Beginning balances	2,877		2,742		2,795		2,655
Shares issued under employee stock purchase plan	—		—		31		27

Purchase of noncontrolling interest	—		—		(2)		—
Treasury shares purchased	—		—		(13)		—
Recognition of stock-based compensation	4		16		70		76
Ending balances	2,881		2,758		2,881		2,758
Retained earnings:
Beginning balances	5,512		4,046		4,412		3,638
Declared dividends	(9)		(11)		(30)		(33)

Net income attributable to Jabil Inc.	129		233		1,250		663
Ending balances	5,632		4,268		5,632		4,268
Accumulated other comprehensive (loss) income:
Beginning balances	(17)		9		(17)		(42)
Total other comprehensive (loss) income	(1)		(20)		(1)		31
Ending balances	(18)		(11)		(18)		(11)
Treasury stock:
Beginning balances	(5,714)		(4,124)		(4,324)		(3,800)
Purchases of treasury stock under employee stock plans	(1)		—		(68)		(36)
Treasury shares purchased	(499)		(154)		(1,811)		(442)
Excise taxes related to treasury shares purchased	(5)		(1)		(16)		(1)
Ending balances	(6,219)		(4,279)		(6,219)		(4,279)
Noncontrolling interests:
Beginning balances	—		1		1		1
Net income attributable to noncontrolling interests	—		—		—		—
Purchase of noncontrolling interest	—		—		(1)		—



Ending balances	—		1		—		1
Total stockholders' equity, ending balances	$	2,276	$	2,737	$	2,276	$	2,737

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

JABIL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(Unaudited)


	Nine months ended
	May 31, 2024		May 31, 2023
Cash flows provided by operating activities:
Net income	$	1,250	$	663
Depreciation, amortization, and other, net	557		752
Gain from the divestiture of businesses	(944)		—







Change in operating assets and liabilities, exclusive of net assets acquired	318		(367)






Net cash provided by operating activities	1,181		1,048
Cash flows provided by (used in) investing activities:
Acquisition of property, plant and equipment	(660)		(860)
Proceeds and advances from sale of property, plant and equipment	115		180
Cash paid for business and intangible asset acquisitions, net of cash	(90)		(30)
Proceeds from the divestiture of businesses, net of cash	2,108		—



Other, net	(6)		(28)
Net cash provided by (used in) investing activities	1,467		(738)
Cash flows used in financing activities:
Borrowings under debt agreements	1,895		3,556
Payments toward debt agreements	(1,987)		(3,369)
Payments to acquire treasury stock	(1,824)		(442)
Dividends paid to stockholders	(32)		(34)
Net proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan	31		27
Treasury stock minimum tax withholding related to vesting of restricted stock	(68)		(36)
Other, net	(4)		(6)
Net cash used in financing activities	(1,989)		(304)
Effect of exchange rate changes on cash and cash equivalents	(6)		(4)
Net increase in cash and cash equivalents	653		2
Cash and cash equivalents at beginning of period	1,804		1,478
Cash and cash equivalents at end of period	$	2,457	$	1,480

See accompanying notes to Condensed Consolidated Financial Statements.

Table of Contents

JABIL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary to present fairly the information set forth therein have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in the Annual Report on Form 10-K of Jabil Inc. (the “Company”) for the fiscal year ended August 31, 2023. Results for the nine months ended May 31, 2024 are not necessarily an indication of the results that may be expected for the full fiscal year ending August 31, 2024.

2. Trade Accounts Receivable Sale Programs

The Company regularly sells designated pools of high credit quality trade accounts receivable, at a discount, under uncommitted trade accounts receivable sale programs to unaffiliated financial institutions without recourse. As these accounts receivable are sold without recourse, the Company does not retain the associated risks following the transfer of such accounts receivable to the respective financial institutions.

As of May 31, 2024, the Company may elect to sell receivables and the unaffiliated financial institutions may elect to purchase specific accounts receivable at any one time, at a discount, on an ongoing basis up to a: (i) maximum aggregate amount available of $1.9 billion under nine trade accounts receivable sale programs, (ii) maximum amount available of 100 million CHF under one trade accounts receivable sale program, (iii) maximum amount available of 8.1 billion INR under one trade accounts receivable sale program, and (iv) maximum amount available of 1.9 billion CNY under one trade accounts receivable sale program. The trade accounts receivable sale programs either expire on various dates through 2028 or do not have expiration dates and may be terminated upon election of the Company or the unaffiliated financial institutions.

The Company continues servicing the receivables sold and in exchange receives an immaterial servicing fee under each of the trade accounts receivable sale programs. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities.

In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Trade accounts receivable sold(1)	$	2,126	$	2,594	$	5,980	$	9,044
Cash proceeds received	$	2,113	$	2,583	$	5,947	$	9,015
Pre-tax losses on sale of receivables(2)	$	13	$	11	$	33	$	29

(1)Receivables sold are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows.

(2)Recorded to other expense within the Condensed Consolidated Statements of Operations.

Table of Contents

3. Inventories

Inventories consist of the following (in millions):


	May 31, 2024		August 31, 2023(1)
Raw materials	$	4,104	$	4,804
Work in process	197		217
Finished goods	190		243
Reserve for excess and obsolete inventory	(52)		(58)
Inventories, net	$	4,439	$	5,206

(1)Excludes $559 million of inventories, net classified as held for sale as of August 31, 2023. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

4. Notes Payable and Long-Term Debt

Notes payable and long-term debt outstanding as of May 31, 2024 and August 31, 2023 are summarized below (in millions):


	Maturity Date	May 31, 2024		August 31, 2023

3.950% Senior Notes	Jan 12, 2028	$	498	$	497
3.600% Senior Notes	Jan 15, 2030	497		496
3.000% Senior Notes	Jan 15, 2031	594		593
1.700% Senior Notes	Apr 15, 2026	498		498
4.250% Senior Notes	May 15, 2027	496		495
5.450% Senior Notes	Feb 1, 2029	296		296
Borrowings under credit facilities(1)(2)	Jan 22, 2026 and Jan 22, 2028	—		—
Borrowings under loans	Jul 31, 2026	—		—
Total notes payable and long-term debt		2,879		2,875
Less current installments of notes payable and long-term debt		—		—
Notes payable and long-term debt, less current installments		$	2,879	$	2,875

(1)On February 23, 2024, the Company entered into an amendment (the “Amendment”) to its senior unsecured credit agreement dated as of January 22, 2020 (as amended, the “Credit Facility”). The Amendment, among other things, (i) instituted certain amendments to the sustainability-linked adjustments to the interest rates applicable to borrowings under the Company’s three-year revolving credit facility (the “Three-Year Revolving Credit Facility”) and the Company’s five-year revolving credit facility (the “Five-Year Revolving Credit Facility”) and (ii) extended the termination date of the Three-Year Revolving Credit Facility (with respect to the available commitments of the extending lenders) to January 22, 2026, and of the Five-Year Revolving Credit Facility (with respect to the available commitments of the extending lenders) to January 22, 2028, in each case subject to an additional one-year extension at the option of the Company.

(2)As of May 31, 2024, the Company has $4.0 billion in available unused borrowing capacity under its revolving credit facilities. The Credit Facility acts as the back-up facility for commercial paper outstanding, if any. The Company has a borrowing capacity of up to $3.2 billion under its commercial paper program.

Table of Contents

Debt Covenants

Borrowings under the Company’s debt agreements are subject to various covenants that limit the Company’s ability to: incur additional indebtedness, sell assets, effect mergers and certain transactions, and effect certain transactions with subsidiaries and affiliates. In addition, the revolving credit facilities contain debt leverage and interest coverage covenants. The Company is also subject to certain covenants requiring the Company to offer to repurchase the 3.950%, 3.600%, 3.000%, 1.700%, 4.250% or 5.450% Senior Notes upon a change of control. As of May 31, 2024 and August 31, 2023, the Company was in compliance with its debt covenants.

Fair Value

Refer to Note 16 – “Fair Value Measurements” for the estimated fair values of the Company’s notes payable and long-term debt.

5. Asset-Backed Securitization Program

Certain Jabil entities participating in the global asset-backed securitization program continuously sell designated pools of trade accounts receivable to a special purpose entity, which in turn sells certain of the receivables at a discount to conduits administered by an unaffiliated financial institution on a monthly basis. In addition, a foreign entity participating in the global asset-backed securitization program sells certain receivables at a discount to conduits administered by an unaffiliated financial institution on a daily basis.

The Company continues servicing the receivables sold and in exchange receives an immaterial servicing fee under the global asset-backed securitization program. The Company does not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as the Company estimates that the fee it receives to service these receivables approximates the fair market compensation to provide the servicing activities.

The special purpose entity in the global asset-backed securitization program is a wholly-owned subsidiary of the Company and is included in the Company’s Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of May 31, 2024.

In connection with the asset-backed securitization program, the Company recognized the following (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Trade accounts receivable sold(1)	$	1,006	$	1,007	$	2,965	$	3,071
Cash proceeds received(2)	$	994	$	996	$	2,931	$	3,043

Pre-tax losses on sale of receivables(3)	$	12	$	11	$	34	$	28

(2)The amounts primarily represent proceeds from collections reinvested in revolving-period transfers.

(3)Recorded to other expense within the Condensed Consolidated Statements of Operations.

Table of Contents

6. Accrued Expenses

Accrued expenses consist of the following (in millions):


	May 31, 2024		August 31, 2023(2)
Inventory deposits	$	1,564	$	1,839
Contract liabilities(1)	977		886
Accrued compensation and employee benefits	635		743


Other accrued expenses	2,753		2,047
Accrued expenses	$	5,929	$	5,515

(1)Revenue recognized during the three months and nine months ended May 31, 2024 that was included in the contract liability balance as of August 31, 2023 was $116 million and $391 million, respectively. Revenue recognized during the three months and nine months ended May 31, 2023 that was included in the contract liability balance as of August 31, 2022 was $99 million and $353 million, respectively.

(2)Excludes $364 million of accrued expenses classified as held for sale as of August 31, 2023. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

7. Postretirement and Other Employee Benefits

Net Periodic Benefit Cost

The following table provides information about the net periodic benefit cost for all plans for the three months and nine months ended May 31, 2024 and 2023 (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Service cost(1)	$	5	$	4	$	15	$	12
Interest cost(2)	3		3		9		9
Expected long-term return on plan assets(2)	(4)		(4)		(13)		(12)
Recognized actuarial gain(2)	(1)		(2)		(4)		(6)
Amortization of actuarial gain(2)(3)	(2)		(2)		(4)		(5)

Amortization of prior service cost(2)	1		1		3		3
Net periodic benefit cost	$	2	$	—	$	6	$	1

(1)Service cost is recognized in cost of revenue in the Condensed Consolidated Statements of Operations.

(2)Components are recognized in other expense in the Condensed Consolidated Statements of Operations.

(3)Actuarial gains and losses are amortized using a corridor approach. The gain/loss corridor is equal to 10 percent of the greater of the projected benefit obligation and the fair value of plan assets. Gains and losses in excess of the corridor are generally amortized over the average future working lifetime of the plan participants.

8. Derivative Financial Instruments and Hedging Activities

The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company’s financial performance and are referred to as market risks. The Company, where deemed appropriate, uses derivatives as risk management tools to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency risk and interest rate risk.

Foreign Currency Risk Management

Forward contracts are put in place to manage the foreign currency risk associated with the anticipated foreign currency denominated revenues and expenses. A hedging relationship existed with an aggregate notional amount outstanding of $283 million and $491 million as of May 31, 2024 and August 31, 2023, respectively. The related forward foreign exchange contracts have been designated as hedging instruments and are accounted for as cash flow hedges. The forward foreign exchange contract transactions will effectively lock in the value of anticipated foreign currency denominated revenues and expenses against foreign currency fluctuations. The anticipated foreign currency denominated revenues and expenses being hedged are expected to occur between June 1, 2024 and May 31, 2025.

Table of Contents

In addition to derivatives that are designated as hedging instruments and qualify for hedge accounting, the Company also enters into forward contracts to economically hedge transactional exposure associated with commitments arising from trade accounts receivable, trade accounts payable, fixed purchase obligations and intercompany transactions denominated in a currency other than the functional currency of the respective operating entity. The aggregate notional amount of these outstanding contracts as of May 31, 2024 and August 31, 2023, was $2.5 billion and $4.0 billion, respectively.

The gains and losses on cash flow hedges recognized in earnings due to amounts excluded from effectiveness testing were not material for all periods presented and are included as components of net revenue, cost of revenue and selling, general and administrative expense, which are the same line items in which the hedged items are recorded.

In addition, the Company has entered into forward foreign currency exchange contracts to hedge a portion of its net investment in foreign currency denominated operations, which are designated as net investment hedges. The maturity dates and aggregate notional amount outstanding of net investment hedges are as follows (in millions):


Maturity date	May 31, 2024		August 31, 2023
September 2023	$	—	$	34
October 2023	—		96
January 2024	—		96
April 2024	—		68
July 2024	176		102
October 2024	115		—
January 2025	101		—
Total	$	392	$	396

The gains and losses on net investment hedges are included in change in foreign currency translation in OCI to offset the change in the carrying value of the net investment being hedged until the complete or substantially complete liquidation of the hedged foreign operation. The amounts excluded from effectiveness testing were not material for all periods presented and are recognized in interest expense, net.

Refer to Note 16 – “Fair Value Measurements” for the fair values and classification of the Company’s derivative instruments.

The following table presents the net gains (losses) from forward contracts recorded in the Condensed Consolidated Statements of Operations for the periods indicated (in millions):


Derivatives Not Designated as Hedging Instruments Under ASC 815	Location of Gain (Loss) on Derivatives Recognized in Net Income	Amount of Gain (Loss) Recognized in Net Income on Derivatives
		Three months ended				Nine months ended
		May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Forward foreign exchange contracts(1)	Cost of revenue	$	—	$	(41)	$	7	$	(57)

(1)For the three months and nine months ended May 31, 2024, the Company recognized $1 million and $36 million, respectively, of foreign currency losses in cost of revenue, which are offset by the gains from the forward foreign exchange contracts. For the three months and nine months ended May 31, 2023, the Company recognized $24 million and $20 million, respectively, of foreign currency gains in cost of revenue, which are offset by the losses from the forward foreign exchange contracts.

Interest Rate Risk Management

The Company periodically enters into interest rate swaps to manage interest rate risk associated with the Company’s borrowings or anticipated debt issuances. As of May 31, 2024, there are no outstanding interest rate swaps.

Table of Contents

9. Accumulated Other Comprehensive Income

The following table sets forth the changes in AOCI, net of tax, by component for the nine months ended May 31, 2024 (in millions):


	Foreign Currency Translation Adjustment		Net Investment Hedges		Derivative Instruments		Actuarial Gain (Loss)		Prior Service (Cost) Credit		Total
Balance as of August 31, 2023	$	(59)	$	(4)	$	14	$	46	$	(14)	$	(17)
Other comprehensive (loss) income before reclassifications	(5)		5		(4)		—		—		(4)

Amounts reclassified from AOCI	(2)		(4)		13		(7)		3		3
Other comprehensive (loss) income(1)	(7)		1		9		(7)		3		(1)
Balance as of May 31, 2024	$	(66)	$	(3)	$	23	$	39	$	(11)	$	(18)

(1)Amounts are net of tax, which are immaterial.

The following table sets forth the amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, net of tax, for the periods indicated (in millions):


		Three months ended				Nine months ended
Comprehensive Income Components	Financial Statement Line Item	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Realized gains on foreign currency translation	Gain from the divestiture of businesses	$	—	$	—	$	(2)	$	—
Realized gains on net investment hedges	Gain from the divestiture of businesses	—		—		(4)		—
Realized (gains) losses on derivative instruments:(1)
Foreign exchange contracts	Cost of revenue	—		(7)		15		37
Interest rate contracts	Interest expense, net	(1)		(1)		(2)		(1)
Realized (gains) losses on pension and postretirement plans:
Actuarial gains	(2)	(2)		(4)		(7)		(11)
Prior service costs	(2)	1		1		3		3
Total amounts reclassified from AOCI(3)		$	(2)	$	(11)	$	3	$	28

(1)The Company expects to reclassify $3 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue.

(2)Amounts are included in the computation of net periodic benefit cost. Refer to Note 7 – “Postretirement and Other Employee Benefits” for additional information.

(3)Amounts are net of tax, which are immaterial for the three months and nine months ended May 31, 2024 and 2023.

10. Stockholders’ Equity

The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Restricted stock units(1)	$	(2)	$	14	$	58	$	68
Employee stock purchase plan	5		4		14		12

Total	$	3	$	18	$	72	$	80

(1)During the three months ended May 31, 2024, the Company recorded a $13 million reversal to stock-based compensation expense primarily due to forfeitures of time-based, performance-based and market-based restricted stock awards.

Table of Contents

As of May 31, 2024, the shares available to be issued under the 2021 Equity Incentive Plan were 8,059,728.

Restricted Stock Units

Certain key employees have been granted time-based, performance-based and market-based restricted stock unit awards (“restricted stock units”). The time-based restricted stock units generally vest on a graded vesting schedule over three years. The performance-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 150%, depending on the specified performance condition and the level of achievement obtained. The performance-based restricted stock units have a vesting condition that is based upon the Company’s cumulative adjusted core earnings per share during the performance period. The market-based restricted stock units generally vest on a cliff vesting schedule over three years and up to a maximum of 200%, depending on the specified performance condition and the level of achievement obtained. The market-based restricted stock units have a vesting condition that is tied to the Company’s total shareholder return based on the Company’s stock performance in relation to the companies in the Standard and Poor’s (S&P) Super Composite Technology Hardware and Equipment Index excluding the Company. During the nine months ended May 31, 2024 and 2023, the Company awarded approximately 0.5 million and 0.9 million time-based restricted stock units, respectively, 0.1 million and 0.2 million performance-based restricted stock units, respectively, and 0.1 million and 0.2 million market-based restricted stock units, respectively.

The following represents the stock-based compensation information as of the period indicated (in millions):


	May 31, 2024
Unrecognized stock-based compensation expense – restricted stock units	$	55
Remaining weighted-average period for restricted stock units expense	1.5 years

Common Stock Outstanding

The following represents the common stock outstanding for the periods indicated:


	Three months ended		Nine months ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Common stock outstanding:
Beginning balances	122,440,607	133,238,368	131,294,422	135,493,980

Shares issued under employee stock purchase plan	—	1,730	338,316	631,066
Vesting of restricted stock	21,550	3,372	1,791,066	2,013,768
Purchases of treasury stock under employee stock plans	(7,512)	(700)	(534,335)	(571,349)
Treasury shares purchased(1)(2)	(3,733,966)	(1,890,906)	(14,168,790)	(6,215,601)
Ending balances	118,720,679	131,351,864	118,720,679	131,351,864

(1)In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2022 Share Repurchase Program”). As of February 28, 2023, 16.5 million shares had been repurchased for $1.0 billion and no authorization remained under the 2022 Share Repurchase Program.

(2)In September 2022, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of the Company’s common stock (the “2023 Share Repurchase Program”). As of August 31, 2023, 2.7 million shares had been repurchased for $224 million, excluding excise tax. In September 2023, the Board of Directors amended and increased the 2023 Share Repurchase Program to allow for the repurchase of up to $2.5 billion of the Company’s common stock. As part of the amended 2023 Share Repurchase Program, the Company entered into an accelerated share repurchase (“ASR”) agreement with a bank in September 2023 to repurchase $500 million of the Company’s common stock. During the first quarter of 2024, the ASR transaction was completed, and 3.9 million shares were delivered under the ASR agreement at an average price of $128.61. The final number of shares delivered upon settlement of the ASR agreement was determined based on a discount to the volume weighted average price of the Company’s common stock during the term of the agreement. As of May 31, 2024, 14.2 million shares had been repurchased for $1.8 billion, excluding excise tax, and $676 million remains available under the amended 2023 Share Repurchase Program.

Table of Contents

In June 2024, as part of the amended 2023 Share Repurchase Program, the Company repurchased $121 million, excluding excise tax, and entered into ASR agreements to repurchase an additional $555 million, excluding excise tax, of the Company’s common stock. Under the ASR agreements, the Company made payments of $555 million to participating financial institutions and received an initial delivery of shares of common stock. The delivery of any remaining shares will occur at the final settlement of the transactions under the ASR agreements.

11. Concentration of Risk and Segment Data

Concentration of Risk

Sales of the Company’s products are concentrated among specific customers. During the nine months ended May 31, 2024, the Company’s five largest customers accounted for approximately 37% of its net revenue and 86 customers accounted for approximately 90% of its net revenue. Sales to these customers were reported in the Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”) operating segments. The DMS segment included the results of the Company’s mobility business prior to the closing of its sale on December 29, 2023.

The Company procures components from a broad group of suppliers. Some of the products manufactured by the Company require one or more components that are available from only a single source.

Segment Data

Net revenue for the operating segments is attributed to the segment in which the service is performed. An operating segment’s performance is evaluated based on its pre-tax operating contribution, or segment income. Segment income is defined as net revenue less cost of revenue, segment selling, general and administrative expenses, segment research and development expenses and an allocation of corporate manufacturing expenses and selling, general and administrative expenses. Certain items are excluded from the calculation of segment income. Transactions between operating segments are generally recorded at amounts that approximate those at which we would transact with third parties.

The following table sets forth operating segment information (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Segment income and reconciliation of income before income tax
EMS	$	195	$	226	$	505	$	629
DMS	155		178		682		627
Total segment income	$	350	$	404	$	1,187	$	1,256
Reconciling items:
Amortization of intangibles	(12)		(7)		(27)		(24)
Stock-based compensation expense and related charges	(3)		(18)		(72)		(80)
Restructuring, severance and related charges(1)	(55)		—		(252)		(45)

Business interruption and impairment charges, net(2)	(14)		—		(14)		—


Gain from the divestiture of businesses(3)	—		—		944		—
Acquisition and divestiture related charges(3)	(3)		—		(64)		—
Other expense (net of periodic benefit cost)	(24)		(22)		(72)		(61)
Interest expense, net	(38)		(51)		(132)		(154)
Income before income tax	$	201	$	306	$	1,498	$	892

(1)Charges recorded during the three months and nine months ended May 31, 2024, related to the 2024 Restructuring Plan. Charges recorded during the nine months ended May 31, 2023, related to headcount reduction to further optimize the Company’s business activities.

(2)Charges recorded during the three months and nine months ended May 31, 2024, related to costs associated with product quality liabilities, which is classified as a component of cost of revenue and selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

Table of Contents

(3)The Company completed the divestiture of its mobility business and recorded a pre-tax gain of $944 million, subject to certain post-closing adjustments that are still being finalized. The Company incurred transaction and disposal costs in connection with the sale of approximately $64 million during the nine months ended May 31, 2024.

The following table presents the Company’s revenues disaggregated by segment (in millions):


	Three months ended
	May 31, 2024						May 31, 2023
	EMS		DMS		Total		EMS		DMS		Total
Timing of transfer
Point in time	$	1,172	$	559	$	1,731	$	1,120	$	1,351	$	2,471
Over time	2,225		2,809		5,034		3,010		2,994		6,004
Total	$	3,397	$	3,368	$	6,765	$	4,130	$	4,345	$	8,475


	Nine months ended
	May 31, 2024						May 31, 2023
	EMS		DMS		Total		EMS		DMS		Total
Timing of transfer
Point in time	$	3,473	$	3,346	$	6,819	$	3,925	$	5,047	$	8,972
Over time	6,847		8,253		15,100		8,802		8,470		17,272
Total	$	10,320	$	11,599	$	21,919	$	12,727	$	13,517	$	26,244

The Company operates in more than 30 countries worldwide. Sales to unaffiliated customers are based on the Company location that maintains the customer relationship and transacts the external sale. The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:


	Three months ended				Nine months ended
	May 31, 2024(1)		May 31, 2023		May 31, 2024(1)		May 31, 2023
Foreign source revenue	80.5	%	86.9	%	83.4	%	85.6	%

(1)Decrease from prior periods is driven by the divestiture of the mobility business during the three months ended February 29, 2024.

12. Restructuring, Severance and Related Charges

Following is a summary of the Company’s restructuring, severance and related charges (in millions):


	Three months ended				Nine months ended
	May 31, 2024(1)		May 31, 2023(2)		May 31, 2024(1)		May 31, 2023(2)
Employee severance and benefit costs	$	33	$	—	$	156	$	36
Lease costs	1		—		2		—
Asset write-off costs	17		—		72		5
Other costs	4		—		22		4
Total restructuring, severance and related charges(3)	$	55	$	—	$	252	$	45

(1)Primarily relates to the 2024 Restructuring Plan.

(2)Primarily relates to headcount reduction to further optimize the Company’s business activities.

(3)Includes $23 million and $0 million recorded in the EMS segment, $15 million and $0 million recorded in the DMS segment and $17 million and $0 million of non-allocated charges for the three months ended May 31, 2024 and 2023, respectively. Includes $63 million and $4 million recorded in the EMS segment, $129 million and $33 million recorded in the DMS segment and $60 million and $8 million of non-allocated charges for the nine months ended May 31, 2024 and 2023, respectively. Except for asset write-off costs, all restructuring, severance and related charges are cash costs.

Table of Contents

2024 Restructuring Plan

On September 26, 2023, the Company’s Board of Directors approved a restructuring plan to (i) realign the Company’s cost base for stranded costs associated with the Company’s sale and realignment of its mobility business and (ii) optimize the Company’s global footprint. This action includes headcount reductions across our Selling, General and Administrative (“SG&A”) cost base and capacity realignment (the “2024 Restructuring Plan”). The 2024 Restructuring Plan reflects the Company’s intention only and restructuring decisions, and the timing of such decisions, at certain locations, are still subject to consultation with the Company’s employees and their representatives.

The Company currently expects to recognize approximately $300 million in pre-tax restructuring and other related costs over the course of the Company’s 2024 fiscal year. The restructuring and other related charges are expected to include $150 million to $180 million of employee severance and benefit costs; $80 million to $120 million of asset write-off costs; and $30 million to $40 million of contract termination costs and other related costs. The amount and timing of the actual charges may vary due to a variety of factors, including the finalization of timetables for the transition of functions, consultation with employees and their representatives, as well as the impact of jurisdictional statutory severance requirements. The Company’s estimates for the charges discussed above exclude any potential income tax effects.

The table below summarizes the Company’s liability activity, primarily associated with the 2024 Restructuring Plan (in millions):


	Employee Severance and Benefit Costs		Lease Costs		Asset Write-off Costs		Other Related Costs		Total
Balance as of August 31, 2023	$	—	$	—	$	—	$	—	$	—
Restructuring related charges	156		2		72		22		252
Asset write-off charge and other non-cash activity	2		—		(72)		(5)		(75)
Cash payments	(91)		(1)		—		(9)		(101)
Balance as of May 31, 2024	$	67	$	1	$	—	$	8	$	76

13. Income Taxes

Effective Income Tax Rate

The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows:


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
U.S. federal statutory income tax rate	21.0	%	21.0	%	21.0	%	21.0	%
Effective income tax rate	35.7	%	24.0	%	16.6	%	25.7	%

The effective income tax rate differed for the three months and nine months ended May 31, 2024, compared to the three months and nine months ended May 31, 2023, primarily due to: (i) a change in the jurisdictional mix of earnings, driven in part by restructuring charges and (ii) the gain from the divestiture of the mobility business and the corresponding $58 million of income tax expense recorded during the three months ended February 29, 2024.

The effective income tax rate differed from the U.S. federal statutory income tax rate of 21.0% during the three months and nine months ended May 31, 2024 and 2023, primarily due to: (i) the jurisdictional mix of earnings, (ii) losses in tax jurisdictions with existing valuation allowances, (iii) tax incentives granted to sites in China, Malaysia, Singapore and Vietnam, and (iv) the gain from the divestiture of the mobility business and the corresponding $58 million of income tax expense recorded during the three months ended February 29, 2024.

14. Earnings Per Share and Dividends

Earnings Per Share

The Company calculates its basic earnings per share by dividing net income attributable to the Company by the weighted average number of common shares outstanding during the period. The Company’s diluted earnings per share is calculated in a similar manner, but includes the effect of dilutive securities. The difference between the weighted average number of basic

Table of Contents

shares outstanding and the weighted average number of diluted shares outstanding is primarily due to dilutive unvested restricted stock units.

Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criteria have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands):

Three months ended

Nine months ended

May 31, 2024

May 31, 2023

May 31, 2024

May 31, 2023

Restricted stock units

261.9

361.2

278.0

361.2

Dividends

The following table sets forth cash dividends declared by the Company to common stockholders during the nine months ended May 31, 2024 and 2023 (in millions, except for per share data):


	Dividend Declaration Date	Dividend per Share		Total of Cash Dividends Declared		Date of Record for Dividend Payment	Dividend Cash Payment Date
Fiscal Year 2024:	October 19, 2023	$	0.08	$	11	November 15, 2023	December 4, 2023
	January 25, 2024	$	0.08	$	10	February 15, 2024	March 4, 2024
	April 17, 2024	$	0.08	$	9	May 15, 2024	June 4, 2024

Fiscal Year 2023:	October 20, 2022	$	0.08	$	12	November 15, 2022	December 2, 2022
	January 26, 2023	$	0.08	$	10	February 15, 2023	March 2, 2023
	April 20, 2023	$	0.08	$	11	May 15, 2023	June 2, 2023

15. Business Acquisitions and Divestitures

Acquisitions

On November 1, 2023, the Company completed the acquisition of ProcureAbility Inc. (“ProcureAbility”) for approximately $60 million in cash. ProcureAbility is a procurement services provider specializing in technology-enabled advisory, managed services, digital, staffing, and recruiting solutions.

The acquisition of ProcureAbility was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $87 million, including $40 million in intangible assets and $38 million in goodwill, and liabilities assumed of $26 million were recorded at their estimated fair values as of the acquisition date. The preliminary estimates and measurements are subject to change during the measurement period for assets acquired, liabilities assumed and tax adjustments. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the DMS segment. The majority of the goodwill is currently not expected to be deductible for income tax purposes. The results of operations were included in the Company’s condensed consolidated financial results beginning on November 1, 2023. Pro forma information has not been provided as the acquisition of ProcureAbility is not deemed to be significant.

Divestitures

The Company announced on September 26, 2023 that, through its indirect subsidiary, Jabil Circuit (Singapore) Pte. Ltd., a Singapore private limited company (“Singapore Seller”), it agreed to sell to an affiliate of BYD Electronic (International) Co. Ltd., a Hong Kong limited liability company (“Purchaser” or “BYDE”), its product manufacturing business in Chengdu, including its supporting component manufacturing in Wuxi (the “Business”) for cash consideration of approximately $2.2 billion, subject to certain customary purchase price adjustments.

Table of Contents

As of August 31, 2023, the Company determined the Business met the criteria to be classified as held for sale. Accordingly, the Company presented the assets and liabilities of the Business as held for sale in the Condensed Consolidated Balance Sheets as of November 30, 2023 and August 31, 2023. Assets and liabilities classified as held for sale had a carrying value less than the estimated fair value less cost to sell and, thus, no adjustment to the carrying value of the disposal group was necessary. Depreciation and amortization expense for long-lived assets was not recorded for the period in which these assets were classified as held for sale. The divestiture did not meet the criteria to be reported as discontinued operations and the Company continued to report the operating results for the Business in the Company’s Condensed Consolidated Statement of Operations in the DMS segment until the Closing Date.

On December 29, 2023 (the “Closing Date”), the Company completed the sale. As a result of the transaction, the Company derecognized net assets of approximately $1.2 billion, and recorded a pre-tax gain of $944 million, subject to certain post-closing adjustments that are still being finalized. In addition, the Company agreed to indemnify the Purchaser from certain liabilities that may arise post-close that relate to periods prior to the Closing Date. The Company incurred transaction and disposal costs in connection with the sale of approximately $64 million during the nine months ended May 31, 2024, which are included in continuing operations in the Company’s Condensed Consolidated Statement of Operations.

The Company performs a goodwill impairment analysis on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In connection with the preparation of the Company’s financial statements for the quarter ended February 29, 2024, the Company completed an impairment analysis for goodwill recorded within the reporting unit impacted by the divestiture of the Business. The quantitative assessment was used, and the Company determined that it is more likely than not that the fair value of the impacted reporting unit is in excess of the carrying value and that no impairment existed subsequent to the closing of the Business. The Company allocated goodwill to the disposal group based on the relative fair value of the Business as compared to the impacted reporting unit.

In the second quarter of fiscal year 2024 and in connection with the divestiture of the Business, the Company made a strategic decision that the indefinite-lived (“Green Point”) trade name valued at $51 million acquired during the acquisition of Green Point should no longer be classified as an indefinite-lived intangible asset. Accordingly, prior to reclassifying the trade name to a finite-lived intangible asset, the Company completed a quantitative assessment for impairment and determined the fair value of the asset exceeded the carrying value. As such, the trade name was assigned a two-year estimated useful life and is being amortized on a straight-line basis as of the Closing Date.

Table of Contents

16. Fair Value Measurements

Fair Value Measurements on a Recurring Basis

The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions):


	Fair Value Hierarchy		May 31, 2024		August 31, 2023
Assets:
Cash and cash equivalents:
Cash equivalents	Level 1	(1)	$	393	$	—
Prepaid expenses and other current assets:
Short-term investments	Level 1		26		25
Forward foreign exchange contracts:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	9		4
Derivatives not designated as hedging instruments (Note 8)	Level 2	(2)	14		20
Net investment hedges:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	8		9




Liabilities:
Accrued expenses:
Forward foreign exchange contracts:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	$	6	$	17
Derivatives not designated as hedging instruments (Note 8)	Level 2	(2)	12		64
Net investment hedges:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	1		1

(1)Consist of time deposits that are readily convertible to cash with original maturities of 90 days or less.

(2)The Company’s forward foreign exchange contracts, including cash flow hedges and net investment hedges are measured on a recurring basis at fair value, based on foreign currency spot rates and forward rates quoted by banks or foreign currency dealers.

Fair Value of Financial Instruments

The carrying amounts of cash and cash equivalents, trade accounts receivable, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value because of the short-term nature of these financial instruments. The carrying amounts of borrowings under credit facilities and under loans approximate fair value as interest rates on these instruments approximate current market rates.

Notes payable and long-term debt is carried at amortized cost; however, the Company estimates the fair values of notes payable and long-term debt for disclosure purposes. The following table presents the carrying amounts and fair values of the Company's notes payable and long-term debt, by hierarchy level as of the periods indicated (in millions):



			May 31, 2024				August 31, 2023
	Fair Value Hierarchy		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Notes payable and long-term debt: (Note 4)

3.950% Senior Notes	Level 2	(1)	$	498	$	473	$	497	$	468
3.600% Senior Notes	Level 2	(1)	$	497	$	448	$	496	$	448
3.000% Senior Notes	Level 2	(1)	$	594	$	510	$	593	$	502
1.700% Senior Notes	Level 2	(1)	$	498	$	465	$	498	$	452
4.250% Senior Notes	Level 2	(1)	$	496	$	482	$	495	$	478
5.450% Senior Notes	Level 2	(1)	$	296	$	299	$	296	$	297

(1)The fair value estimates are based upon observable market data.

Table of Contents

17. Commitments and Contingencies

Legal Proceedings

The Company is party to certain lawsuits in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial position, results of operations or cash flows.

18. New Accounting Guidance

New accounting guidance adopted during the period did not have a material impact to the Company.

Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.

Table of Contents

JABIL INC. AND SUBSIDIARIES

This Quarterly Report on Form 10-Q contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Many of the forward-looking statements are located in Item 2 of this Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “should,” “could,” “can,” “may,” and similar terms. Forward-looking statements are not guarantees of future performance and the Company’s actual results may differ significantly from the results discussed in the forward-looking statements. Achievement of anticipated results is subject to substantial risks, uncertainties and inaccurate assumptions. Should these risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements, and you are cautioned not to put undue reliance on forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. You are advised, however, to consult any further disclosures we make on related subjects. Factors that might cause such differences include, but are not limited to, those discussed in Part II, Item 1A to this Quarterly Report on Form 10-Q and in Part 1, Item 1A of the Company’s Annual Report on Form 10-K for the year ended August 31, 2023 such as, unexpected costs or unexpected liabilities that may arise from the Mobility transaction; scheduling production, managing growth and capital expenditures and maximizing the efficiency of our manufacturing capacity effectively; managing rapid declines or increases in customer demand and other related customer challenges that may occur; the effect of COVID-19 and its impact on our operations, sites, customers and supply chain; our dependence on a limited number of customers; our ability to purchase components efficiently and reliance on a limited number of suppliers for critical components; risks arising from relationships with emerging companies; changes in technology and competition in our industry; our ability to introduce new business models or programs requiring implementation of new competencies; competition; transportation issues; our ability to maintain our engineering, technological and manufacturing expertise; retaining key personnel; risks associated with international sales and operations, including geopolitical uncertainties; energy price increases or shortages; our ability to achieve expected profitability from acquisitions; risk arising from our restructuring activities; issues involving our information systems, including security issues; regulatory risks (including the expense of complying, or failing to comply, with applicable regulations; risk arising from design or manufacturing defects; risk arising from compliance, or failure to comply, with environmental, health and safety laws or regulations and intellectual property risk); financial risks (including customers or suppliers who become financially troubled; turmoil in financial markets; tax risks; credit rating risks; risks of exposure to debt; currency fluctuations; and asset impairment); changes in financial accounting standards or policies; risk of natural disaster, climate change or other global events; and risks arising from expectations relating to environmental, social and governance considerations. References in this report to “the Company,” “Jabil,” “we,” “our,” or “us” mean Jabil Inc. together with its consolidated subsidiaries, except where the context otherwise requires.

Table of Contents


Item 2.			Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

We are one of the leading providers of worldwide manufacturing services and solutions. We provide comprehensive electronics design, production and product management services to companies in various industries and end markets. Our services enable our customers to reduce manufacturing costs, improve supply-chain management, reduce inventory obsolescence, lower transportation costs and reduce product fulfillment time. Our manufacturing and supply chain management services and solutions include innovation, design, planning, fabrication and assembly, delivery and managing the flow of resources and products. We derive substantially all of our revenue from production and product management services (collectively referred to as “manufacturing services”), which encompass the act of producing tangible components that are built to customer specifications and are then provided to the customer.

We serve our customers primarily through dedicated business units that combine highly automated, continuous flow manufacturing with advanced electronic design and design for manufacturability. We currently depend, and expect to continue to depend for the foreseeable future, upon a relatively small number of customers for a significant percentage of our net revenue, which in turn depends upon their growth, viability and financial stability.

We conduct our operations in facilities that are located worldwide, including but not limited to, China, India, Malaysia, Mexico, Singapore and the United States. We derived a substantial majority, 80.5% and 83.4%, of net revenue from our international operations for the three months and nine months ended May 31, 2024, respectively. Our global manufacturing production sites allow customers to manufacture products simultaneously in the optimal locations for their products. Our global presence is key to assessing and executing on our business opportunities.

We have two reporting segments: Electronics Manufacturing Services (“EMS”) and Diversified Manufacturing Services (“DMS”), which are organized based on the economic profiles of the services performed, including manufacturing capabilities, market strategy, margins, return on capital and risk profiles. Our EMS segment is focused around leveraging IT, supply chain design and engineering, technologies largely centered on core electronics, utilizing our large scale manufacturing infrastructure and our ability to serve a broad range of end markets. Our EMS segment is a high volume business that produces product at a quicker rate (i.e. cycle time) and in larger quantities and includes customers primarily in the 5G, wireless and cloud, digital print and retail, industrial and semi-capital equipment, and networking and storage industries. Our DMS segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies and healthcare. Our DMS segment includes customers primarily in the automotive and transportation, connected devices, healthcare and packaging, and mobility industries.

On December 29, 2023, we completed the sale of our product manufacturing business in Chengdu, including its supporting component manufacturing in Wuxi for pre-tax cash proceeds of approximately $2.2 billion, subject to certain post-closing adjustments. The sale of the Business represented the divestiture of our mobility business. See Note 15 – “Business Acquisitions and Divestitures” to the Consolidated Financial Statements for additional information.

We monitor the current economic environment and its potential impact on both the customers we serve as well as our end-markets and closely manage our costs and capital resources so that we can respond appropriately as circumstances change.

Refer to Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" section contained in our Annual Report on Form 10-K for the fiscal year ended August 31, 2023 for further discussion of the items disclosed in Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations" section as of May 31, 2024 contained herein.

Table of Contents

Summary of Results

The following table sets forth, for the periods indicated, certain key operating results and other financial information (in millions, except per share data):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Net revenue	$	6,765	$	8,475	$	21,919	$	26,244
Gross profit	$	608	$	697	$	2,013	$	2,101
Operating income	$	261	$	375	$	1,695	$	1,096
Net income attributable to Jabil Inc.	$	129	$	233	$	1,250	$	663
Earnings per share – basic	$	1.08	$	1.76	$	10.01	$	4.96
Earnings per share – diluted	$	1.06	$	1.72	$	9.86	$	4.86

Key Performance Indicators

Management regularly reviews financial and non-financial performance indicators to assess the Company’s operating results. Changes in our operating assets and liabilities are largely affected by our working capital requirements, which are dependent on the effective management of our sales cycle as well as timing of payments. Our sales cycle measures how quickly we can convert our manufacturing services into cash through sales. We believe the metrics set forth below are useful to investors in measuring our liquidity as future liquidity needs will depend on fluctuations in levels of inventory, accounts receivable and accounts payable.

The following table sets forth, for the quarterly periods indicated, certain of management’s key financial performance indicators:

Three months ended

May 31, 2024

February 29, 2024

May 31, 2023

Sales cycle(1)

47 days

48 days

Inventory turns (annualized)(2)

4 turns

Days in accounts receivable(3)

45 days

35 days

38 days

Days in inventory(4)

81 days

87 days

84 days

Days in accounts payable(5)

79 days

74 days

(1)The sales cycle is calculated as the sum of days in accounts receivable and days in inventory, less the days in accounts payable; accordingly, the variance in the sales cycle quarter over quarter was a direct result of changes in these indicators.

(2)Inventory turns (annualized) are calculated as 360 days divided by days in inventory.

(3)Days in accounts receivable is calculated as accounts receivable, net, divided by net revenue multiplied by 90 days. During the three months ended May 31, 2024, the increase in days in accounts receivable from the prior sequential quarter and the three months ended May 31, 2023, was primarily driven by timing of collections.

(4)Days in inventory is calculated as inventories, net and contract assets divided by cost of revenue multiplied by 90 days. During the three months ended May 31, 2024, the decrease in days in inventory from the prior sequential quarter and the three months ended May 31, 2023, was primarily driven by higher consumption of inventory to support sales during the quarter and improved working capital management.

(5)Days in accounts payable is calculated as accounts payable divided by cost of revenue multiplied by 90 days. During the three months ended May 31, 2024, the increase in days in accounts payable from the prior sequential quarter and the three months ended May 31, 2023, was primarily due to timing of purchases and cash payments during the quarter.

Table of Contents

Critical Accounting Policies and Estimates

The preparation of our Condensed Consolidated Financial Statements and related disclosures in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and judgments that affect our reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions based upon historical experience and various other factors and circumstances. Management believes that our estimates and assumptions are reasonable under the circumstances; however, actual results may vary from these estimates and assumptions under different future circumstances. For further discussion of our significant accounting policies, refer to Note 1 — “Description of Business and Summary of Significant Accounting Policies” to the Consolidated Financial Statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” in our Annual Report on Form 10-K for the fiscal year ended August 31, 2023.

Recent Accounting Pronouncements

See Note 18 – “New Accounting Guidance” to the Condensed Consolidated Financial Statements for a discussion of recent accounting guidance.

Results of Operations

Net Revenue

Generally, we assess revenue on a global customer basis regardless of whether the growth is associated with organic growth or as a result of an acquisition. Accordingly, we do not differentiate or separately report revenue increases generated by acquisitions as opposed to existing business. In addition, the added cost structures associated with our acquisitions have historically been relatively insignificant when compared to our overall cost structure.

The distribution of revenue across our segments has fluctuated, and will continue to fluctuate, as a result of numerous factors, including the following: fluctuations in customer demand; efforts to diversify certain portions of our business; business growth from new and existing customers; specific product performance; and any potential termination, or substantial winding down, of significant customer relationships.


	Three months ended						Nine months ended
(dollars in millions)	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Net revenue	$	6,765	$	8,475	(20.2)	%	$	21,919	$	26,244	(16.5)	%

Net revenue decreased during the three months ended May 31, 2024, compared to the three months ended May 31, 2023. Specifically, the DMS segment net revenue decreased 23% due to: (i) a 18% decrease primarily driven by the divestiture of our mobility business, (ii) a 3% decrease in revenues from existing customers within our connected devices business, (iii) a 1% decrease in revenues from existing customers within our healthcare and packaging businesses, and (iv) a 1% decrease in revenues from existing customers within our automotive and transportation business. The EMS segment net revenue decreased 18% primarily due to: (i) a 7% decrease in revenues from existing customers within our industrial and semi-capital equipment business, (ii) a 5% decrease in revenues from existing customers primarily within our 5G and wireless business, and the continued transitioning to a customer-controlled consignment model in our cloud business during fiscal year 2024, (iii) a 4% decrease in revenues from existing customers within our networking and storage business, and (iv) a 2% decrease in revenues from existing customers within our digital print and retail business.

Net revenue decreased during the nine months ended May 31, 2024, compared to the nine months ended May 31, 2023. Specifically, the EMS segment net revenue decreased 19% primarily due to: (i) a 10% decrease in revenues from existing customers within our 5G, wireless and cloud business, primarily driven by the continued transitioning to a customer-controlled consignment model in our cloud business during fiscal year 2024, (ii) a 5% decrease in revenues from existing customers within our digital print and retail business, and (iii) a 4% decrease in revenues from existing customers within our industrial and semi-capital equipment business. The DMS segment net revenue decreased 14% due to: (i) a 12% decrease primarily driven by the divestiture of our mobility business and (ii) a 4% decrease in revenues from existing customers within our connected devices business. The decrease is partially offset by a 2% increase in revenues from existing customers within our automotive and transportation business.

Table of Contents

On September 26, 2023, we announced the signing of a definitive agreement to divest our mobility business to an affiliate of BYD Electronic (International) Company Limited (“BYDE”) in a cash transaction valued at approximately $2.2 billion, subject to certain customary purchase price adjustments. On December 29, 2023, the Closing Date, we completed the sale. See Note 15 – “Business Acquisitions and Divestitures” to the Consolidated Financial Statements for additional information.

The following table sets forth, for the periods indicated, revenue by segment expressed as a percentage of net revenue:


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
EMS	50	%	49	%	47	%	48	%
DMS	50	%	51	%	53	%	52	%
Total	100	%	100	%	100	%	100	%

The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:


	Three months ended				Nine months ended
	May 31, 2024(1)		May 31, 2023		May 31, 2024(1)		May 31, 2023
Foreign source revenue	80.5	%	86.9	%	83.4	%	85.6	%

(1)Decrease from prior periods is driven by the divestiture of our mobility business during the three months ended February 29, 2024.

Gross Profit


	Three months ended						Nine months ended
(dollars in millions)	May 31, 2024			May 31, 2023			May 31, 2024			May 31, 2023
Gross profit	$	608		$	697		$	2,013		$	2,101
Percent of net revenue	9.0		%	8.2		%	9.2		%	8.0		%

Gross profit as a percentage of net revenue increased for the three months and nine months ended May 31, 2024, compared to the three months and nine months ended May 31, 2023, primarily due to product mix and depreciation and amortization for long-lived assets related to the mobility divestiture no longer being recorded while these assets were classified as held for sale.

Selling, General and Administrative


	Three months ended						Nine months ended
(in millions)	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Selling, general and administrative	$	268	$	307	$	(39)	$	890	$	911	$	(21)

Selling, general and administrative expenses decreased during the three months ended May 31, 2024, compared to the three months ended May 31, 2023, primarily due to a decrease in stock-based compensation expense associated with forfeitures of time-based, performance-based and market-based restricted stock awards during the three months ended May 31, 2024 and a decrease in salary and salary related expenses.

Selling, general and administrative expenses decreased during the nine months ended May 31, 2024, compared to the nine months ended May 31, 2023, primarily due to a decrease in stock-based compensation expense associated with forfeitures of time-based, performance-based and market-based restricted stock awards.

Research and Development


	Three months ended						Nine months ended
(dollars in millions)	May 31, 2024			May 31, 2023			May 31, 2024			May 31, 2023
Research and development	$	9		$	8		$	29		$	25
Percent of net revenue	0.1		%	0.1		%	0.1		%	0.1		%

Research and development expenses remained consistent as a percentage of net revenue during the three months and nine months ended May 31, 2024, compared to the three months and nine months ended May 31, 2023.

Table of Contents

Amortization of Intangibles


	Three months ended						Nine months ended
(in millions)	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Amortization of intangibles	$	12	$	7	$	5	$	27	$	24	$	3

Amortization of intangibles increased during the three months and nine months ended May 31, 2024, compared to the three months and nine months ended May 31, 2023, primarily due to amortization related to the Green Point trade name, which was reclassified to a definite-lived intangible asset during fiscal year 2024.

Restructuring, Severance and Related Charges


	Three months ended						Nine months ended
(in millions)	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Restructuring, severance and related charges	$	55	$	—	$	55	$	252	$	45	$	207

Restructuring, severance and related charges increased during the three months and nine months ended May 31, 2024, compared to the three months and nine months ended May 31, 2023, primarily due to charges related to the 2024 Restructuring Plan.

2024 Restructuring Plan

On September 26, 2023, our Board of Directors approved a restructuring plan to (i) realign our cost base for stranded costs associated with the sale and realignment of our mobility business and (ii) optimize our global footprint. This action includes headcount reductions across our Selling, General and Administrative (“SG&A”) cost base and capacity realignment (the “2024 Restructuring Plan”). The 2024 Restructuring Plan reflects our intention only and restructuring decisions, and the timing of such decisions, at certain locations, are still subject to consultation with our employees and their representatives.

Based on the analysis done to date, we currently expect to recognize approximately $300 million in pre-tax restructuring and other related costs over the course of our 2024 fiscal year. The restructuring and other related charges are expected to include $150 million to $180 million of employee severance and benefit costs; $80 million to $120 million of asset write-off costs; and $30 million to $40 million of contract termination costs and other related costs. The charges relating to the 2024 Restructuring Plan are currently expected to result in net cash expenditures of approximately $200 million that will be payable over the course of our fiscal years 2024 and 2025. The exact timing of these charges and cash outflows, as well as the estimated cost ranges by category type, have not been finalized. The amount and timing of the actual charges may vary due to a variety of factors, including the finalization of timetables for the transition of functions, consultation with employees and their representatives, as well as the impact of jurisdictional statutory severance requirements. Our estimates for the charges discussed above exclude any potential income tax effects.

See Note 12 – “Restructuring, Severance and Related Charges” to the Condensed Consolidated Financial Statements for further discussion of restructuring, severance and related charges.

Gain from the Divestiture of Businesses


	Three months ended						Nine months ended
(in millions)	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Gain from the divestiture of businesses	$	—	$	—	$	—	$	(944)	$	—	$	(944)

In the second quarter of fiscal year 2024, we completed the divestiture of our mobility business. As a result of the transaction, we recorded a pre-tax gain of $944 million, subject to certain post-closing adjustments that are still being finalized.

See Note 15 – “Business Acquisitions and Divestitures” to the Condensed Consolidated Financial Statements for additional information.

Table of Contents

Acquisition and Divestiture Related Charges


	Three months ended						Nine months ended
(in millions)	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Acquisition and divestiture related charges	$	3	$	—	$	3	$	64	$	—	$	64

Acquisition and divestiture related charges recorded during the three months and nine months ended May 31, 2024, related to transaction and disposal costs incurred in connection with the divestiture of our mobility business.

See Note 15 – “Business Acquisitions and Divestitures” to the Condensed Consolidated Financial Statements for additional information.

Other Expense


	Three months ended						Nine months ended
(in millions)	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Other expense	$	22	$	18	$	4	$	65	$	50	$	15

Other expense increased during the three months ended May 31, 2024, compared to the three months ended May 31, 2023, is primarily due to an increase in fees due to higher utilization of our trade accounts receivable sales programs and global asset-backed securitization program, as well as higher interest rates on these programs.

Other expense increased during the nine months ended May 31, 2024, compared to the nine months ended May 31, 2023, primarily due to an increase in fees due to higher interest rates on our trade accounts receivable sales programs and global asset-backed securitization program, as well as higher utilization of our global asset-backed securitization program.

Interest Expense, Net


	Three months ended						Nine months ended
(in millions)	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Interest expense, net	$	38	$	51	$	(13)	$	132	$	154	$	(22)

Interest expense, net decreased during the three months ended May 31, 2024, compared to the three months ended May 31, 2023, primarily due to lower borrowings on our credit facilities and commercial paper program.

Interest expense, net decreased during the nine months ended May 31, 2024, compared to the nine months ended May 31, 2023, due to lower borrowings primarily on our credit facilities and commercial paper program. The decrease is partially offset by an increase due to higher interest rates primarily on our credit facilities and commercial paper program.

Income Tax Expense


	Three months ended						Nine months ended
	May 31, 2024		May 31, 2023		Change		May 31, 2024		May 31, 2023		Change
Effective income tax rate	35.7	%	24.0	%	11.7	%	16.6	%	25.7	%	(9.1)	%

The European Union (EU) and other countries have committed to enacting substantial changes that would reshape international tax rules, including the introduction of a global minimum tax. In December 2022, the EU approved a directive requiring member states to incorporate a 15% global minimum tax applied on a country-by-country basis into their respective laws effective for fiscal years beginning on or after December 31, 2023. In addition, several non-EU countries have recently proposed and/or adopted legislation consistent with the global minimum tax framework. As legislation becomes effective in more countries in which we do business, our taxes could increase and negatively impact our provision for income taxes. We continue to monitor pending legislation and implementation by countries and evaluate the potential impact on our business in fiscal year 2025 and future periods.

Table of Contents

Non-GAAP (Core) Financial Measures

The following discussion and analysis of our financial condition and results of operations include certain non-GAAP financial measures as identified in the reconciliations below. The non-GAAP financial measures disclosed herein do not have standard meaning and may vary from the non-GAAP financial measures used by other companies or how we may calculate those measures in other instances from time to time. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with U.S. GAAP. Among other uses, management uses non-GAAP “core” financial measures to make operating decisions, assess business performance and as a factor in determining certain employee performance when evaluating incentive compensation. Also, our “core” financial measures should not be construed as an indication by us that our future results will be unaffected by those items that are excluded from our “core” financial measures.

We determine an annual normalized tax rate (“normalized core tax rate”) for the computation of the non-GAAP (core) income tax provision to provide better consistency across reporting periods. In estimating the normalized core tax rate annually, we utilize a full-year financial projection of core earnings that considers the mix of earnings across tax jurisdictions, existing tax positions, and other significant tax matters. We may adjust the normalized core tax rate during the year for material impacts from new tax legislation or material changes to our operations.

Included in the tables below are reconciliations of the non-GAAP financial measures to the most directly comparable U.S. GAAP financial measures as provided in our Condensed Consolidated Financial Statements:

Reconciliation of U.S. GAAP Financial Results to Non-GAAP Measures


	Three months ended				Nine months ended
(in millions, except for per share data)	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Operating income (U.S. GAAP)	$	261	$	375	$	1,695	$	1,096
Amortization of intangibles	12		7		27		24
Stock-based compensation expense and related charges	3		18		72		80
Restructuring, severance and related charges(1)	55		—		252		45

Net periodic benefit cost(2)	2		4		7		11
Business interruption and impairment charges, net(3)	14		—		14		—

Gain from the divestiture of businesses(4)	—		—		(944)		—
Acquisition and divestiture related charges(4)	3		—		64		—
Adjustments to operating income	89		29		(508)		160
Core operating income (Non-GAAP)	$	350	$	404	$	1,187	$	1,256
Net income attributable to Jabil Inc. (U.S. GAAP)	$	129	$	233	$	1,250	$	663
Adjustments to operating income	89		29		(508)		160


Net periodic benefit cost(2)	(2)		(4)		(7)		(11)
Adjustments for taxes(5)	14		11		51		32
Core earnings (Non-GAAP)	$	230	$	269	$	786	$	844


Diluted earnings per share (U.S. GAAP)	$	1.06	$	1.72	$	9.86	$	4.86


Diluted core earnings per share (Non-GAAP)	$	1.89	$	1.99	$	6.20	$	6.18


Diluted weighted average shares outstanding (U.S. GAAP and Non-GAAP)	121.7		135.1		126.9		136.4

(2)We are reclassifying the pension components in other expense to core operating income as we assess operating performance, inclusive of all components of net periodic benefit cost, with the related revenue. There is no impact to core earnings or diluted core earnings per share for this adjustment.

(3)Charges recorded during the three months and nine months ended May 31, 2024, related to costs associated with product quality liabilities, which is classified as a component of cost of revenue and selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

Table of Contents

(4)We completed the divestiture of our mobility business and recorded a pre-tax gain of $944 million, subject to certain post-closing adjustments that are still being finalized. We incurred transaction and disposal costs in connection with the sale of approximately $64 million during the nine months ended May 31, 2024.

(5)Tax adjustments for the nine months ended May 31, 2024, were partially driven by an income tax expense associated with the divestiture of the mobility business.

Adjusted Free Cash Flow


	Nine months ended
(in millions)	May 31, 2024		May 31, 2023
Net cash provided by operating activities (U.S. GAAP)	$	1,181	$	1,048
Acquisition of property, plant and equipment (“PP&E”)(1)	(660)		(860)
Proceeds and advances from sale of PP&E(1)	115		180
Adjusted free cash flow (Non-GAAP)	$	636	$	368

(1)Certain customers co-invest in PP&E with us. As we acquire PP&E, we recognize the cash payments in acquisition of PP&E. When our customers reimburse us and obtain control, we recognized the cash receipts in proceeds and advances from the sale of PP&E.

Acquisitions and Divestitures

Acquisitions

On November 1, 2023, we completed the acquisition of ProcureAbility Inc. (“ProcureAbility”) for approximately $60 million in cash. ProcureAbility is a procurement services provider specializing in technology-enabled advisory, managed services, digital, staffing, and recruiting solutions.

The acquisition of ProcureAbility was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $87 million, including $40 million in intangible assets and $38 million in goodwill, and liabilities assumed of $26 million were recorded at their estimated fair values as of the acquisition date. The preliminary estimates and measurements are subject to change during the measurement period for assets acquired, liabilities assumed and tax adjustments. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the DMS segment. The majority of the goodwill is currently not expected to be deductible for income tax purposes. The results of operations were included in our condensed consolidated financial results beginning on November 1, 2023. Pro forma information has not been provided as the acquisition of ProcureAbility is not deemed to be significant.

Divestitures

We announced on September 26, 2023 that, through our indirect subsidiary, Jabil Circuit (Singapore) Pte. Ltd., a Singapore private limited company (“Singapore Seller”), we agreed to sell to an affiliate of BYD Electronic (International) Co. Ltd., a Hong Kong limited liability company (“Purchaser” or “BYDE”), our product manufacturing business in Chengdu, including our supporting component manufacturing in Wuxi (the “Business”) for cash consideration of approximately $2.2 billion, subject to certain customary purchase price adjustments.

As of August 31, 2023, we determined the Business met the criteria to be classified as held for sale. Accordingly, we presented the assets and liabilities of the Business as held for sale in the Consolidated Balance Sheets as of November 30, 2023 and August 31, 2023. Asset and liabilities classified as held for sale had a carrying value less than the estimated fair value less cost to sell and, thus, no adjustment to the carrying value of the disposal group was necessary. Depreciation and amortization expense for long-lived assets was not recorded for the period in which these assets were classified as held for sale. The divestiture did not meet the criteria to be reported as discontinued operations and we continued to report the operating results for the Business in the Condensed Consolidated Statement of Operations in the DMS segment until the Closing Date.

On December 29, 2023, the Closing Date, we completed the sale. As a result of the transaction, we derecognized net assets of approximately $1.2 billion, and recorded a pre-tax gain of $944 million, subject to certain post-closing adjustments that are still being finalized. In addition, we agreed to indemnify the Purchaser from certain liabilities that may arise post-close that relate to periods prior to the Closing Date. We incurred transaction and disposal costs in connection with the sale of approximately $64 million during the nine months ended May 31, 2024, which are included in continuing operations in the Condensed Consolidated Statement of Operations.

Table of Contents

We perform a goodwill impairment analysis on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In connection with the preparation of the Company’s financial statements for the quarter ended February 29, 2024, we completed an impairment analysis for goodwill recorded within the reporting unit impacted by the divestiture of the Business. The quantitative assessment was used, and we determined that it is more likely than not that the fair value of the impacted reporting unit is in excess of the carrying value and that no impairment existed subsequent to the closing of the Business. We allocated goodwill to the disposal group based on the relative fair value of the Business as compared to the impacted reporting unit.

In the second quarter of fiscal year 2024 and in connection with the divestiture of the Business, we made a strategic decision that the indefinite-lived (“Green Point”) trade name valued at $51 million acquired during the acquisition of Green Point should no longer be classified as an indefinite-lived intangible asset. Accordingly, prior to reclassifying the trade name to a finite-lived intangible asset, we completed a quantitative assessment for impairment and determined the fair value of the asset exceeded the carrying value. As such, the trade name was assigned a two-year estimated useful life and is being amortized on a straight-line basis as of the Closing Date.

Refer to Note 15 – “Business Acquisitions and Divestitures” to the Condensed Consolidated Financial Statements for discussion.

Liquidity and Capital Resources

We believe that our level of liquidity sources, which includes cash on hand, available borrowings under our revolving credit facilities and commercial paper program, additional proceeds available under our global asset-backed securitization program and under our uncommitted trade accounts receivable sale programs, cash flows provided by operating activities and access to the capital markets, will be adequate to fund our capital expenditures, the payment of any declared quarterly dividends, any share repurchases under the approved programs, any potential acquisitions, our working capital requirements and our contractual obligations for the next 12 months and beyond. We continue to assess our capital structure and evaluate the merits of redeploying available cash.

Cash and Cash Equivalents

As of May 31, 2024, we had approximately $2.5 billion in cash and cash equivalents, of which a significant portion was held by our foreign subsidiaries. Most of our foreign cash and cash equivalents as of May 31, 2024 could be repatriated to the United States without potential tax expense.

Notes Payable and Credit Facilities

Following is a summary of principal debt payments and debt issuance for our notes payable and credit facilities:


(in millions)	3.950% Senior Notes		3.600% Senior Notes		3.000% Senior Notes		1.700% Senior Notes		4.250% Senior Notes		5.450% Senior Notes		Borrowings under revolving credit facilities(1)(2)		Borrowings under loans		Total notes payable and credit facilities
Balance as of August 31, 2023	$	497	$	496	$	593	$	498	$	495	$	296	$	—	$	—	$	2,875
Borrowings	—		—		—		—		—		—		1,895		—		1,895
Payments	—		—		—		—		—		—		(1,895)		—		(1,895)
Other	1		1		1		—		1		—		—		—		4
Balance as of May 31, 2024	$	498	$	497	$	594	$	498	$	496	$	296	$	—	$	—	$	2,879
Maturity Date	Jan 12, 2028		Jan 15, 2030		Jan 15, 2031		Apr 15, 2026		May 15, 2027		Feb 1, 2029		Jan 22, 2026 and Jan 22, 2028		Jul 31, 2026
Original Facility/ Maximum Capacity	$500 million		$500 million		$600 million		$500 million		$500 million		$300 million		$4.0 billion(2)		$1 million

(1)On February 23, 2024, we entered into an amendment (the “Amendment”) to our senior unsecured credit agreement dated as of January 22, 2020 (as amended, the “Credit Facility”). The Amendment, among other things, (i) instituted certain amendments to the sustainability-linked adjustments to the interest rates applicable to borrowings under the three-year revolving credit facility (the “Three-Year Revolving Credit Facility”) and the five-year revolving credit facility (the “Five-Year Revolving Credit Facility”) and (ii) extended the termination date of the Three-Year Revolving Credit Facility (with respect to the available commitments of the extending lenders) to January 22, 2026, and of the

Table of Contents

Five-Year Revolving Credit Facility (with respect to the available commitments of the extending lenders) to January 22, 2028, in each case subject to an additional one-year extension at the option of the Company.

(2)As of May 31, 2024, we had $4.0 billion in available unused borrowing capacity under our revolving credit facilities. The Credit Facility acts as the back-up facility for commercial paper outstanding, if any. We have a borrowing capacity of up to $3.2 billion under our commercial paper program. Commercial paper borrowings with an original maturity of 90 days or less are recorded net within the Condensed Consolidated Statements of Cash Flows, and have been excluded from the table above.

We have a shelf registration statement with the SEC registering the potential sale of an indeterminate amount of debt and equity securities in the future to augment our liquidity and capital resources.

Our Senior Notes and our credit facilities contain various financial and nonfinancial covenants. A violation of these covenants could negatively impact our liquidity by restricting our ability to borrow under the notes payable and credit facilities and potentially causing acceleration of amounts due under these notes payable and credit facilities. As of May 31, 2024 and August 31, 2023, we were in compliance with our debt covenants. Refer to Note 4 – “Notes Payable and Long-Term Debt” to the Condensed Consolidated Financial Statements for further details.

Global Asset-Backed Securitization Program

We continue servicing the receivables sold and in exchange receive an immaterial servicing fee under the global asset-backed securitization program. We do not record a servicing asset or liability on the Condensed Consolidated Balance Sheets as we estimate that the fee we receive to service these receivables approximates the fair market compensation to provide the servicing activities.

The special purpose entity in the global asset-backed securitization program is a wholly-owned subsidiary of the Company and is included in our Condensed Consolidated Financial Statements. Certain unsold receivables covering up to the maximum amount of net cash proceeds available under the domestic, or U.S., portion of the global asset-backed securitization program are pledged as collateral to the unaffiliated financial institution as of May 31, 2024.

The global asset-backed securitization program expires on November 25, 2024. Effective February 20, 2024, the terms of the global asset-backed securitization program were amended to increase the maximum amount of net cash proceeds available at any one time from $600 million to $700 million. During the three months and nine months ended May 31, 2024, we sold $1.0 billion and $3.0 billion, respectively, of trade accounts receivable and we received cash proceeds of $1.0 billion and $2.9 billion, respectively. As of May 31, 2024, we had no available liquidity under our global asset-backed securitization program.

The global asset-backed securitization program requires compliance with several covenants including compliance with the interest ratio and debt to EBITDA ratio of the Credit Facility. As of May 31, 2024 and August 31, 2023, we were in compliance with all covenants under our global asset-backed securitization program. Refer to Note 5 – “Asset-Backed Securitization Program” to the Condensed Consolidated Financial Statements for further details on the program.

Trade Accounts Receivable Sale Programs

As of May 31, 2024, we may elect to sell receivables and the unaffiliated financial institutions may elect to purchase specific accounts receivable at any one time, at a discount, on an ongoing basis up to a: (i) maximum aggregate amount available of $1.9 billion under nine trade accounts receivable sale programs, (ii) maximum amount available of 100 million CHF under one trade accounts receivable sale program, (iii) maximum amount available of 8.1 billion INR under one trade accounts receivable sale program, and (iv) maximum amount available of 1.9 billion CNY under one trade accounts receivable sale program. The trade accounts receivable sale programs either expire on various dates through 2028 or do not have expiration dates and may be terminated upon election of the Company or the unaffiliated financial institutions.

During the three months and nine months ended May 31, 2024, we sold $2.1 billion and $6.0 billion, respectively, of trade accounts receivable under these programs and we received cash proceeds of $2.1 billion and $5.9 billion, respectively. As of May 31, 2024, we had up to $693 million in available liquidity under our trade accounts receivable sale programs.

Table of Contents

Cash Flows

The following table sets forth selected consolidated cash flow information (in millions):


	Nine months ended
	May 31, 2024		May 31, 2023
Net cash provided by operating activities	$	1,181	$	1,048
Net cash provided by (used in) investing activities	1,467		(738)
Net cash used in financing activities	(1,989)		(304)
Effect of exchange rate changes on cash and cash equivalents	(6)		(4)
Net increase in cash and cash equivalents	$	653	$	2

Operating Activities

Net cash provided by operating activities during the nine months ended May 31, 2024, was primarily due to a decrease in inventories and non-cash expenses and net income. Net cash provided by operating activities was partially offset by an increase in prepaid expenses and other current assets, a decrease in accounts payable, accrued expense and other liabilities, an increase in contract assets and an increase in accounts receivable. The decrease in inventories is primarily due to higher consumption of inventory to support sales and improved working capital management. The increase in prepaid expenses and other current assets is primarily due to the timing of payments. The decrease in accounts payable, accrued expenses and other liabilities is primarily due to the timing of purchases and cash payments. The increase in contract assets is primarily due to timing of revenue recognition for the over time customers. The increase in accounts receivable is primarily driven by the timing of collections.

Investing Activities

Net cash provided by investing activities during the nine months ended May 31, 2024, consisted primarily of proceeds from the divestiture of our mobility business and proceeds and advances from the sale of property, plant and equipment, partially offset by capital expenditures, principally to support ongoing business in the DMS and EMS segments and the acquisition of ProcureAbility and certain other third party assets.

Financing Activities

Net cash used in financing activities during the nine months ended May 31, 2024, was primarily due to (i) payments for debt agreements, (ii) the repurchase of our common stock under our share repurchase authorization, (iii) treasury stock minimum tax withholding related to vesting of restricted stock, and (iv) dividend payments. Net cash used in financing activities was partially offset by (i) borrowings under debt agreements and (ii) net proceeds from the exercise of stock options and issuance of common stock under the employee stock purchase plan.

Capital Expenditures

For Fiscal Year 2024, we anticipate our net capital expenditures to be in the range of 2.2 percent to 2.5 percent of net revenue. Upon closing of the Company’s sale of its mobility business, we anticipate our longer-term net capital expenditures to be in the range of 2.0 to 2.3 percent of net revenue. In general, our capital expenditures support ongoing maintenance in our DMS and EMS segments and investments in capabilities and targeted end markets. The amount of actual capital expenditures may be affected by general economic, financial, competitive, legislative and regulatory factors, among other things.

Dividends and Share Repurchases

We currently expect to continue to declare and pay regular quarterly dividends of an amount similar to our past declarations. However, the declaration and payment of future dividends are discretionary and will be subject to determination by our Board of Directors each quarter following its review of our financial performance and global economic conditions.

In July 2021, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of our common stock (the “2022 Share Repurchase Program”). As of February 28, 2023, 16.5 million shares had been repurchased for $1.0 billion and no authorization remained under the 2022 Share Repurchase Program.

Table of Contents

In September 2022, the Board of Directors approved an authorization for the repurchase of up to $1.0 billion of our common stock (the “2023 Share Repurchase Program”). As of August 31, 2023, 2.7 million shares had been repurchased for $224 million, excluding excise tax. In September 2023, the Board of Directors amended and increased the 2023 Share Repurchase Program to allow for the repurchase of up to $2.5 billion of our common stock. As part of the amended 2023 Share Repurchase Program, we entered into an accelerated share repurchase (“ASR”) agreement with a bank in September 2023 to repurchase $500 million of our common stock. During the first quarter of 2024, the ASR transaction was completed, and 3.9 million shares were delivered under the ASR agreement at an average price of $128.61. The final number of shares delivered upon settlement of the ASR agreement was determined based on a discount to the volume weighted average price of our common stock during the term of the agreement. As of May 31, 2024, 14.2 million shares had been repurchased for $1.8 billion, excluding excise tax, and $676 million remains available under the amended 2023 Share Repurchase Program.

Contractual Obligations

As of the date of this report, there were no material changes outside the ordinary course of business, since August 31, 2023, to our contractual obligations and commitments and the related cash requirements.


Item 3.			Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our primary risk exposures or management of market risks from those disclosed in our Annual Report on Form 10-K for the fiscal year ended August 31, 2023.


Item 4.			Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation required by Rules 13a-15 and 15d-15 under the Exchange Act (the “Evaluation”), under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15 and 15d-15 under the Exchange Act as of May 31, 2024. Based on the Evaluation, our CEO and CFO concluded that the design and operation of our disclosure controls were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) accumulated and communicated to our senior management, including our CEO and CFO, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

For our fiscal quarter ended May 31, 2024, we did not identify any modifications to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION


Item 1.			Legal Proceedings

See the discussion in Note 17 - “Commitments and Contingencies” to the Condensed Consolidated Financial Statements.


Item 1A.			Risk Factors

For information regarding risk factors that could affect our business, results of operations, financial condition or future results, see Part I, “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended August 31, 2023. For further information on our forward-looking statements see Part I of this Quarterly Report on Form 10-Q.


Item 2.			Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information relating to our repurchase of common stock, excluding excise tax, during the three months ended May 31, 2024:


Period	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Program(2)	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (in millions)(2)
March 1, 2024 – March 31, 2024	1,843,540	$	131.15	1,843,452	$	934
April 1, 2024 – April 30, 2024	1,897,938	$	136.09	1,890,514	$	676
May 1, 2024 – May 31, 2024	—	$	—	—	$	676
Total	3,741,478	$	133.66	3,733,966

(1)The purchases include amounts that are attributable to 7,512 shares surrendered to us by employees to satisfy, in connection with the vesting of restricted stock unit awards, their tax withholding obligations.

(2)In September 2022, our Board of Directors authorized the repurchase of up to $1.0 billion of our common stock as publicly announced in a press release on September 27, 2022 (the “2023 Share Repurchase Program”). As of August 31, 2023, 2.7 million shares had been repurchased for $224 million, excluding excise tax. In September 2023, our Board of Directors amended and increased the 2023 Share Repurchase Program to allow for the repurchase of up to $2.5 billion of our common stock as publicly announced in a press release on September 28, 2023.


Item 3.			Defaults Upon Senior Securities

None.


Item 4.			Mine Safety Disclosures

Not applicable.


Item 5.			Other Information

During the three months ended May 31, 2024, no director or executive officer of the Company adopted or terminated a trading arrangement intended to satisfy the affirmative defenses of Rule 10b5-1 under the Securities Exchange Act of 1934 or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K.

Table of Contents


Item 6.			Exhibits

Index to Exhibits

Incorporated by Reference Herein

Exhibit No.

Description

Form

Exhibit

Filing Date/Period End Date

3.1

Registrant’s Certificate of Incorporation, as amended.

10-Q

3.1

5/31/2017

3.2

Registrant’s Bylaws, as amended.

10-K

3.2

8/31/2022

4.1

Form of Certificate for Shares of the Registrant’s Common Stock. (P)

S-1

3/17/1993

4.2

Indenture, dated January 16, 2008, with respect to Senior Debt Securities of the Registrant, between the Registrant and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee.

8-K

4.2

1/17/2008

4.3

Form of 5.450% Senior Notes due 2029 (included as Exhibit A to the Officers’ Certificate filed herewith as Exhibit 4.5).

8-K

4.1

4/13/2023

4.4

Form of 4.250% Registered Senior Notes due 2027 (included as Exhibit A to the Officers’ Certificate filed herewith as Exhibit 4.6).

8-K

4.1

5/4/2022

4.5

Officers’ Certificate, dated as of April 13, 2023, establishing the 5.450% Senior Notes due 2029.

8-K

4.1

4/13/2023

4.6

Officers’ Certificate, dated as of May 4, 2022, establishing the 4.250% Senior Notes due 2027.

8-K

4.1

5/4/2022

4.7

Officers’ Certificate, dated as of April 14, 2021, establishing the 1.700% Senior Notes due 2026.

8-K

4.1

4/14/2021

4.8

Officers’ Certificate, dated as of July 13, 2020, establishing the 3.000% Senior Notes due 2031.

8-K

4.1

7/13/2020

4.9

Officers’ Certificate, dated as of January 15, 2020, establishing the 3.600% Senior Notes due 2030.

8-K

4.1

1/15/2020

4.10

Officers’ Certificate, dated as of January 17, 2018, establishing the 3.950% Senior Notes due 2028.

8-K

4.1

1/17/2018

10.1†**

Separation, Release and Restrictive Covenants Agreement between Kenneth S. Wilson and Jabil Inc. dated May 19, 2024.

8-K

10.1

5/20/2024

10.2†**

Amendment to Mutual Separation Agreement and Release dated as of May 19, 2024 between Jabil Inc. and Steven D. Borges.

8-K

10.2

5/20/2024

10.3†**

Mutual Separation Agreement and Release dated May 24, 2024, between Jabil Inc. and Gerald (“JJ”) Creadon.

8-K

10.1

5/31/2024

31.1*

Rule 13a-14(a)/15d-14(a) Certification by the Chief Executive Officer.

31.2*

Rule 13a-14(a)/15d-14(a) Certification by the Chief Financial Officer.

32.1*

Section 1350 Certification by the Chief Executive Officer.

32.2*

Section 1350 Certification by the Chief Financial Officer.

101

The following financial information from Jabil’s Quarterly Report on Form 10-Q for the quarterly period ended May 31, 2024, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets as of May 31, 2024 and August 31, 2023, (ii) Condensed Consolidated Statements of Operations for the three months and nine months ended May 31, 2024 and 2023, (iii) Condensed Consolidated Statements of Comprehensive Income for the three months and nine months ended May 31, 2024 and 2023, (iv) Condensed Consolidated Statements of Stockholders’ Equity for the three months and nine months ended May 31, 2024 and 2023, (v) Condensed Consolidated Statements of Cash Flows for the nine months ended May 31, 2024 and 2023, and (vi) the Notes to Condensed Consolidated Financial Statements.

104

Cover Page Interactive Data File (Embedded within the inline XBRL Document in Exhibit 101).

Table of Contents

†

Indicates management compensatory plan, contract or arrangement

Filed or furnished herewith

Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. Jabil agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon request.

Certain instruments with respect to long-term debt of the Registrant and its consolidated subsidiaries are not filed herewith pursuant to Item 601(b)(4)(iii) of Regulation S-K since the total amount of securities authorized under each such instrument does not exceed 10% of the total assets of the Registrant and its subsidiaries on a consolidated basis. The Registrant agrees to furnish a copy of any such instrument to the Securities and Exchange Commission upon request.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	JABIL INC. Registrant

Date: July 9, 2024	By:	/s/ MICHAEL DASTOOR
		Michael Dastoor Chief Executive Officer

Date: July 9, 2024	By:	/s/ GREGORY B. HEBARD
		Gregory B. Hebard Chief Financial Officer

EXHIBIT 31.1

CERTIFICATIONS

I, Michael Dastoor, certify that:


1.			I have reviewed this quarterly report on Form 10-Q of Jabil Inc.;


2.			Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.			Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.			The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a – 15(e) and 15d – 15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:


			a)			Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


			b)			Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


			c)			Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


			d)			Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.			The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


			a)			All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


			b)			Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: July 9, 2024						/s/ MICHAEL DASTOOR
						Michael Dastoor
						Chief Executive Officer

EXHIBIT 31.2

CERTIFICATIONS

I, Gregory B. Hebard, certify that:


1.			I have reviewed this quarterly report on Form 10-Q of Jabil Inc.;


2.			Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.			Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.			The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a – 15(e) and 15d – 15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the registrant and have:


			a)			Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


			b)			Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


			c)			Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


			d)			Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.			The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


			a)			All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


			b)			Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: July 9, 2024						/s/ GREGORY B. HEBARD
						Gregory B. Hebard
						Chief Financial Officer

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Jabil Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended May 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Michael Dastoor, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: July 9, 2024						/s/ MICHAEL DASTOOR
						Michael Dastoor
						Chief Executive Officer

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Jabil Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended May 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Gregory B. Hebard, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: July 9, 2024						/s/ GREGORY B. HEBARD
						Gregory B. Hebard
						Chief Financial Officer

Cover Page - shares	9 Months Ended
Cover Page - shares	May 31, 2024	Jul. 02, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	May 31, 2024
Document Transition Report	false
Entity File Number	001-14063
Entity Registrant Name	JABIL INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	38-1886260
Entity Address, Address Line One	10800 Roosevelt Boulevard North
Entity Address, City or Town	St. Petersburg
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33716
City Area Code	727
Local Phone Number	577-9749
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	JBL
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		113,445,192
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000898293
Current Fiscal Year End Date	--08-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	May 31, 2024	Aug. 31, 2023
Current assets:
Cash and cash equivalents	$ 2,457	$ 1,804
Accounts receivable, net of allowance for credit losses	3,382	3,647
Contract assets	1,121	1,035
Inventories, net of reserve for excess and obsolete inventory	4,439	5,206
Prepaid expenses and other current assets	1,494	1,109
Assets held for sale	0	1,929
Total current assets	12,893	14,730
Property, plant and equipment, net of accumulated depreciation of $4,668 as of May 31, 2024 and $4,512 as of August 31, 2023	2,963	3,137
Operating lease right-of-use asset	366	367
Goodwill	655	621
Intangible assets, net of accumulated amortization	155	142
Deferred income taxes	129	159
Other assets	288	268
Total assets	17,449	19,424
Current liabilities:
Current installments of notes payable and long-term debt	0	0
Accounts payable	5,398	5,679
Accrued expenses	5,929	5,515
Current operating lease liabilities	96	104
Liabilities held for sale	0	1,397
Total current liabilities	11,423	12,695
Notes payable and long-term debt, less current installments	2,879	2,875
Other liabilities	331	319
Non-current operating lease liabilities	285	269
Income tax liabilities	112	131
Deferred income taxes	143	268
Total liabilities	15,173	16,557
Commitments and contingencies
Jabil Inc. stockholders’ equity:
Preferred stock, $0.001 par value, authorized 10,000,000 shares; no shares issued and no shares outstanding	0	0
Common stock, $0.001 par value, authorized 500,000,000 shares; 276,079,193 and 273,949,811 shares issued and 118,720,679 and 131,294,422 shares outstanding as of May 31, 2024 and August 31, 2023, respectively	0	0
Additional paid-in capital	2,881	2,795
Retained earnings	5,632	4,412
Accumulated other comprehensive loss	(18)	(17)
Treasury stock at cost, 157,358,514 and 142,655,389 shares as of May 31, 2024 and August 31, 2023, respectively	(6,219)	(4,324)
Total Jabil Inc. stockholders’ equity	2,276	2,866
Noncontrolling interests	0	1
Total equity	2,276	2,867
Total liabilities and equity	$ 17,449	$ 19,424

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	May 31, 2024	Aug. 31, 2023
Statement of Financial Position [Abstract]
Accumulated depreciation	$ 4,668	$ 4,512
Preferred stock, par value (in usd per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	276,079,193	273,949,811
Common stock, shares outstanding (in shares)	118,720,679	131,294,422
Treasury stock at cost, shares (in shares)	157,358,514	142,655,389

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Income Statement [Abstract]
Net revenue	$ 6,765	$ 8,475	$ 21,919	$ 26,244
Cost of revenue	6,157	7,778	19,906	24,143
Gross profit	608	697	2,013	2,101
Operating expenses:
Selling, general and administrative	268	307	890	911
Research and development	9	8	29	25
Amortization of intangibles	12	7	27	24
Restructuring, severance and related charges	55	0	252	45
Gain from the divestiture of businesses	0	0	(944)	0
Acquisition and divestiture related charges	3	0	64	0
Operating income	261	375	1,695	1,096
Other expense	22	18	65	50
Interest expense, net	38	51	132	154
Income before income tax	201	306	1,498	892
Income tax expense	72	73	248	229
Net income	129	233	1,250	663
Net income attributable to noncontrolling interests, net of tax	0	0	0	0
Net income attributable to Jabil Inc.	$ 129	$ 233	$ 1,250	$ 663
Earnings per share attributable to the stockholders of Jabil Inc.:
Basic (in usd per share)	$ 1.08	$ 1.76	$ 10.01	$ 4.96
Diluted (in usd per share)	$ 1.06	$ 1.72	$ 9.86	$ 4.86
Weighted average shares outstanding:
Basic (in shares)	119.9	132.3	124.9	133.6
Diluted (in shares)	121.7	135.1	126.9	136.4

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 129	$ 233	$ 1,250	$ 663
Other comprehensive income (loss):
Change in foreign currency translation	1	3	(6)	21
Change in derivative instruments:
Change in fair value of derivatives	0	(13)	(4)	(20)
Adjustment for net (gains) losses realized and included in net income	(1)	(8)	13	36
Total change in derivative instruments	(1)	(21)	9	16
Actuarial loss	(2)	(3)	(7)	(8)
Prior service credit	1	1	3	2
Total other comprehensive (loss) income	(1)	(20)	(1)	31
Comprehensive income	128	213	1,249	694
Comprehensive income attributable to noncontrolling interests	0	0	0	0
Comprehensive income attributable to Jabil Inc.	$ 128	$ 213	$ 1,249	$ 694

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Additional paid-in capital:	Retained earnings:	Accumulated other comprehensive (loss) income:	Treasury stock:	Noncontrolling interests:
Beginning Balance at Aug. 31, 2022	$ 2,452	$ 2,655	$ 3,638	$ (42)	$ (3,800)	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock purchase plan		27
Treasury shares purchased					(442)
Recognition of stock-based compensation		76
Declared dividends			(33)
Net income attributable to Jabil Inc.	663		663
Total other comprehensive (loss) income	31			31
Purchases of treasury stock under employee stock plans					(36)
Excise taxes related to treasury shares purchased					(1)
Ending Balance at May. 31, 2023	2,737	2,758	4,268	(11)	(4,279)	1
Beginning Balance at Feb. 28, 2023	2,674	2,742	4,046	9	(4,124)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares purchased					(154)
Recognition of stock-based compensation		16
Declared dividends			(11)
Net income attributable to Jabil Inc.	233		233
Total other comprehensive (loss) income	(20)			(20)
Excise taxes related to treasury shares purchased					(1)
Ending Balance at May. 31, 2023	2,737	2,758	4,268	(11)	(4,279)	1
Beginning Balance at Aug. 31, 2023	2,867	2,795	4,412	(17)	(4,324)	1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under employee stock purchase plan		31
Purchase of noncontrolling interest		(2)				(1)
Treasury shares purchased		(13)			(1,811)
Recognition of stock-based compensation		70
Declared dividends			(30)
Net income attributable to Jabil Inc.	1,250		1,250
Total other comprehensive (loss) income	(1)			(1)
Purchases of treasury stock under employee stock plans					(68)
Excise taxes related to treasury shares purchased					(16)
Ending Balance at May. 31, 2024	2,276	2,881	5,632	(18)	(6,219)	0
Beginning Balance at Feb. 29, 2024	2,658	2,877	5,512	(17)	(5,714)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares purchased					(499)
Recognition of stock-based compensation		4
Declared dividends			(9)
Net income attributable to Jabil Inc.	129		129
Total other comprehensive (loss) income	(1)			(1)
Purchases of treasury stock under employee stock plans					(1)
Excise taxes related to treasury shares purchased					(5)
Ending Balance at May. 31, 2024	$ 2,276	$ 2,881	$ 5,632	$ (18)	$ (6,219)	$ 0

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	May 31, 2024	May 31, 2023
Cash flows provided by operating activities:
Net income	$ 1,250	$ 663
Depreciation, amortization, and other, net	557	752
Gain from the divestiture of businesses	(944)	0
Change in operating assets and liabilities, exclusive of net assets acquired	318	(367)
Net cash provided by operating activities	1,181	1,048
Cash flows provided by (used in) investing activities:
Acquisition of property, plant and equipment	(660)	(860)
Proceeds and advances from sale of property, plant and equipment	115	180
Cash paid for business and intangible asset acquisitions, net of cash	(90)	(30)
Proceeds from the divestiture of businesses, net of cash	2,108	0
Other, net	(6)	(28)
Net cash provided by (used in) investing activities	1,467	(738)
Cash flows used in financing activities:
Borrowings under debt agreements	1,895	3,556
Payments toward debt agreements	(1,987)	(3,369)
Payments to acquire treasury stock	(1,824)	(442)
Dividends paid to stockholders	(32)	(34)
Net proceeds from exercise of stock options and issuance of common stock under employee stock purchase plan	31	27
Treasury stock minimum tax withholding related to vesting of restricted stock	(68)	(36)
Other, net	(4)	(6)
Net cash used in financing activities	(1,989)	(304)
Effect of exchange rate changes on cash and cash equivalents	(6)	(4)
Net increase in cash and cash equivalents	653	2
Cash and cash equivalents at beginning of period	1,804	1,478
Cash and cash equivalents at end of period	$ 2,457	$ 1,480

Basis of Presentation	9 Months Ended
Basis of Presentation	May 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) necessary to present fairly the information set forth therein have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and footnotes included in the Annual Report on Form 10-K of Jabil Inc. (the “Company”) for the fiscal year ended August 31, 2023. Results for the nine months ended May 31, 2024 are not necessarily an indication of the results that may be expected for the full fiscal year ending August 31, 2024.

Trade Accounts Receivable Sale Programs

9 Months Ended

May 31, 2024

Transfers and Servicing [Abstract]

Trade Accounts Receivable Sale Programs

In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Trade accounts receivable sold(1)	$	2,126	$	2,594	$	5,980	$	9,044
Cash proceeds received	$	2,113	$	2,583	$	5,947	$	9,015
Pre-tax losses on sale of receivables(2)	$	13	$	11	$	33	$	29

(2)Recorded to other expense within the Condensed Consolidated Statements of Operations.

Asset-Backed Securitization Program

In connection with the asset-backed securitization program, the Company recognized the following (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Trade accounts receivable sold(1)	$	1,006	$	1,007	$	2,965	$	3,071
Cash proceeds received(2)	$	994	$	996	$	2,931	$	3,043

Pre-tax losses on sale of receivables(3)	$	12	$	11	$	34	$	28

(2)The amounts primarily represent proceeds from collections reinvested in revolving-period transfers.

(3)Recorded to other expense within the Condensed Consolidated Statements of Operations.

Inventories

9 Months Ended

May 31, 2024

Inventory Disclosure [Abstract]

Inventories

Inventories consist of the following (in millions):


	May 31, 2024		August 31, 2023(1)
Raw materials	$	4,104	$	4,804
Work in process	197		217
Finished goods	190		243
Reserve for excess and obsolete inventory	(52)		(58)
Inventories, net	$	4,439	$	5,206

(1)Excludes $559 million of inventories, net classified as held for sale as of August 31, 2023. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

Notes Payable and Long-Term Debt

9 Months Ended

May 31, 2024

Debt Disclosure [Abstract]

Notes Payable and Long-Term Debt

Notes payable and long-term debt outstanding as of May 31, 2024 and August 31, 2023 are summarized below (in millions):


	Maturity Date	May 31, 2024		August 31, 2023

3.950% Senior Notes	Jan 12, 2028	$	498	$	497
3.600% Senior Notes	Jan 15, 2030	497		496
3.000% Senior Notes	Jan 15, 2031	594		593
1.700% Senior Notes	Apr 15, 2026	498		498
4.250% Senior Notes	May 15, 2027	496		495
5.450% Senior Notes	Feb 1, 2029	296		296
Borrowings under credit facilities(1)(2)	Jan 22, 2026 and Jan 22, 2028	—		—
Borrowings under loans	Jul 31, 2026	—		—
Total notes payable and long-term debt		2,879		2,875
Less current installments of notes payable and long-term debt		—		—
Notes payable and long-term debt, less current installments		$	2,879	$	2,875

Debt Covenants

Fair Value

Refer to Note 16 – “Fair Value Measurements” for the estimated fair values of the Company’s notes payable and long-term debt.

Asset-Backed Securitization Program

9 Months Ended

May 31, 2024

Transfers and Servicing [Abstract]

Asset-Backed Securitization Program

Trade Accounts Receivable Sale Programs

In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Trade accounts receivable sold(1)	$	2,126	$	2,594	$	5,980	$	9,044
Cash proceeds received	$	2,113	$	2,583	$	5,947	$	9,015
Pre-tax losses on sale of receivables(2)	$	13	$	11	$	33	$	29

(2)Recorded to other expense within the Condensed Consolidated Statements of Operations.

Asset-Backed Securitization Program

In connection with the asset-backed securitization program, the Company recognized the following (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Trade accounts receivable sold(1)	$	1,006	$	1,007	$	2,965	$	3,071
Cash proceeds received(2)	$	994	$	996	$	2,931	$	3,043

Pre-tax losses on sale of receivables(3)	$	12	$	11	$	34	$	28

(2)The amounts primarily represent proceeds from collections reinvested in revolving-period transfers.

(3)Recorded to other expense within the Condensed Consolidated Statements of Operations.

Accrued Expenses

9 Months Ended

May 31, 2024

Accrued Liabilities, Current [Abstract]

Accrued Expenses

Accrued expenses consist of the following (in millions):


	May 31, 2024		August 31, 2023(2)
Inventory deposits	$	1,564	$	1,839
Contract liabilities(1)	977		886
Accrued compensation and employee benefits	635		743


Other accrued expenses	2,753		2,047
Accrued expenses	$	5,929	$	5,515

(2)Excludes $364 million of accrued expenses classified as held for sale as of August 31, 2023. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

Postretirement and Other Employee Benefits

9 Months Ended

May 31, 2024

Retirement Benefits [Abstract]

Postretirement and Other Employee Benefits

Net Periodic Benefit Cost

The following table provides information about the net periodic benefit cost for all plans for the three months and nine months ended May 31, 2024 and 2023 (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Service cost(1)	$	5	$	4	$	15	$	12
Interest cost(2)	3		3		9		9
Expected long-term return on plan assets(2)	(4)		(4)		(13)		(12)
Recognized actuarial gain(2)	(1)		(2)		(4)		(6)
Amortization of actuarial gain(2)(3)	(2)		(2)		(4)		(5)

Amortization of prior service cost(2)	1		1		3		3
Net periodic benefit cost	$	2	$	—	$	6	$	1

(1)Service cost is recognized in cost of revenue in the Condensed Consolidated Statements of Operations.

(2)Components are recognized in other expense in the Condensed Consolidated Statements of Operations.

Derivative Financial Instruments and Hedging Activities

9 Months Ended

May 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments and Hedging Activities

Foreign Currency Risk Management


Maturity date	May 31, 2024		August 31, 2023
September 2023	$	—	$	34
October 2023	—		96
January 2024	—		96
April 2024	—		68
July 2024	176		102
October 2024	115		—
January 2025	101		—
Total	$	392	$	396

Refer to Note 16 – “Fair Value Measurements” for the fair values and classification of the Company’s derivative instruments.

The following table presents the net gains (losses) from forward contracts recorded in the Condensed Consolidated Statements of Operations for the periods indicated (in millions):


Derivatives Not Designated as Hedging Instruments Under ASC 815	Location of Gain (Loss) on Derivatives Recognized in Net Income	Amount of Gain (Loss) Recognized in Net Income on Derivatives
		Three months ended				Nine months ended
		May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Forward foreign exchange contracts(1)	Cost of revenue	$	—	$	(41)	$	7	$	(57)

Interest Rate Risk Management

Accumulated Other Comprehensive Income

9 Months Ended

May 31, 2024

Equity [Abstract]

Accumulated Other Comprehensive Income

The following table sets forth the changes in AOCI, net of tax, by component for the nine months ended May 31, 2024 (in millions):


	Foreign Currency Translation Adjustment		Net Investment Hedges		Derivative Instruments		Actuarial Gain (Loss)		Prior Service (Cost) Credit		Total
Balance as of August 31, 2023	$	(59)	$	(4)	$	14	$	46	$	(14)	$	(17)
Other comprehensive (loss) income before reclassifications	(5)		5		(4)		—		—		(4)

Amounts reclassified from AOCI	(2)		(4)		13		(7)		3		3
Other comprehensive (loss) income(1)	(7)		1		9		(7)		3		(1)
Balance as of May 31, 2024	$	(66)	$	(3)	$	23	$	39	$	(11)	$	(18)

(1)Amounts are net of tax, which are immaterial.


		Three months ended				Nine months ended
Comprehensive Income Components	Financial Statement Line Item	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Realized gains on foreign currency translation	Gain from the divestiture of businesses	$	—	$	—	$	(2)	$	—
Realized gains on net investment hedges	Gain from the divestiture of businesses	—		—		(4)		—
Realized (gains) losses on derivative instruments:(1)
Foreign exchange contracts	Cost of revenue	—		(7)		15		37
Interest rate contracts	Interest expense, net	(1)		(1)		(2)		(1)
Realized (gains) losses on pension and postretirement plans:
Actuarial gains	(2)	(2)		(4)		(7)		(11)
Prior service costs	(2)	1		1		3		3
Total amounts reclassified from AOCI(3)		$	(2)	$	(11)	$	3	$	28

(1)The Company expects to reclassify $3 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue.

(2)Amounts are included in the computation of net periodic benefit cost. Refer to Note 7 – “Postretirement and Other Employee Benefits” for additional information.

(3)Amounts are net of tax, which are immaterial for the three months and nine months ended May 31, 2024 and 2023.

Stockholders' Equity

9 Months Ended

May 31, 2024

Share-Based Payment Arrangement [Abstract]

Stockholders' Equity

Stockholders’ Equity

The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Restricted stock units(1)	$	(2)	$	14	$	58	$	68
Employee stock purchase plan	5		4		14		12

Total	$	3	$	18	$	72	$	80

As of May 31, 2024, the shares available to be issued under the 2021 Equity Incentive Plan were 8,059,728.

Restricted Stock Units

The following represents the stock-based compensation information as of the period indicated (in millions):


	May 31, 2024
Unrecognized stock-based compensation expense – restricted stock units	$	55
Remaining weighted-average period for restricted stock units expense	1.5 years

Common Stock Outstanding

The following represents the common stock outstanding for the periods indicated:


	Three months ended		Nine months ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Common stock outstanding:
Beginning balances	122,440,607	133,238,368	131,294,422	135,493,980

Shares issued under employee stock purchase plan	—	1,730	338,316	631,066
Vesting of restricted stock	21,550	3,372	1,791,066	2,013,768
Purchases of treasury stock under employee stock plans	(7,512)	(700)	(534,335)	(571,349)
Treasury shares purchased(1)(2)	(3,733,966)	(1,890,906)	(14,168,790)	(6,215,601)
Ending balances	118,720,679	131,351,864	118,720,679	131,351,864

Concentration of Risk and Segment Data

9 Months Ended

May 31, 2024

Segment Reporting [Abstract]

Concentration of Risk and Segment Data

Concentration of Risk

The Company procures components from a broad group of suppliers. Some of the products manufactured by the Company require one or more components that are available from only a single source.

Segment Data

The following table sets forth operating segment information (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Segment income and reconciliation of income before income tax
EMS	$	195	$	226	$	505	$	629
DMS	155		178		682		627
Total segment income	$	350	$	404	$	1,187	$	1,256
Reconciling items:
Amortization of intangibles	(12)		(7)		(27)		(24)
Stock-based compensation expense and related charges	(3)		(18)		(72)		(80)
Restructuring, severance and related charges(1)	(55)		—		(252)		(45)

Business interruption and impairment charges, net(2)	(14)		—		(14)		—


Gain from the divestiture of businesses(3)	—		—		944		—
Acquisition and divestiture related charges(3)	(3)		—		(64)		—
Other expense (net of periodic benefit cost)	(24)		(22)		(72)		(61)
Interest expense, net	(38)		(51)		(132)		(154)
Income before income tax	$	201	$	306	$	1,498	$	892

The following table presents the Company’s revenues disaggregated by segment (in millions):


	Three months ended
	May 31, 2024						May 31, 2023
	EMS		DMS		Total		EMS		DMS		Total
Timing of transfer
Point in time	$	1,172	$	559	$	1,731	$	1,120	$	1,351	$	2,471
Over time	2,225		2,809		5,034		3,010		2,994		6,004
Total	$	3,397	$	3,368	$	6,765	$	4,130	$	4,345	$	8,475


	Nine months ended
	May 31, 2024						May 31, 2023
	EMS		DMS		Total		EMS		DMS		Total
Timing of transfer
Point in time	$	3,473	$	3,346	$	6,819	$	3,925	$	5,047	$	8,972
Over time	6,847		8,253		15,100		8,802		8,470		17,272
Total	$	10,320	$	11,599	$	21,919	$	12,727	$	13,517	$	26,244


	Three months ended				Nine months ended
	May 31, 2024(1)		May 31, 2023		May 31, 2024(1)		May 31, 2023
Foreign source revenue	80.5	%	86.9	%	83.4	%	85.6	%

(1)Decrease from prior periods is driven by the divestiture of the mobility business during the three months ended February 29, 2024.

Restructuring, Severance and Related Charges

9 Months Ended

May 31, 2024

Restructuring and Related Activities [Abstract]

Restructuring, Severance and Related Charges

Following is a summary of the Company’s restructuring, severance and related charges (in millions):


	Three months ended				Nine months ended
	May 31, 2024(1)		May 31, 2023(2)		May 31, 2024(1)		May 31, 2023(2)
Employee severance and benefit costs	$	33	$	—	$	156	$	36
Lease costs	1		—		2		—
Asset write-off costs	17		—		72		5
Other costs	4		—		22		4
Total restructuring, severance and related charges(3)	$	55	$	—	$	252	$	45

(1)Primarily relates to the 2024 Restructuring Plan.

(2)Primarily relates to headcount reduction to further optimize the Company’s business activities.

2024 Restructuring Plan

The table below summarizes the Company’s liability activity, primarily associated with the 2024 Restructuring Plan (in millions):


	Employee Severance and Benefit Costs		Lease Costs		Asset Write-off Costs		Other Related Costs		Total
Balance as of August 31, 2023	$	—	$	—	$	—	$	—	$	—
Restructuring related charges	156		2		72		22		252
Asset write-off charge and other non-cash activity	2		—		(72)		(5)		(75)
Cash payments	(91)		(1)		—		(9)		(101)
Balance as of May 31, 2024	$	67	$	1	$	—	$	8	$	76

Income Taxes

9 Months Ended

May 31, 2024

Income Tax Disclosure [Abstract]

Income Taxes

Effective Income Tax Rate

The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows:


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
U.S. federal statutory income tax rate	21.0	%	21.0	%	21.0	%	21.0	%
Effective income tax rate	35.7	%	24.0	%	16.6	%	25.7	%

Earnings Per Share and Dividends

9 Months Ended

May 31, 2024

Earnings Per Share [Abstract]

Earnings Per Share and Dividends

Earnings Per Share

shares outstanding and the weighted average number of diluted shares outstanding is primarily due to dilutive unvested restricted stock units.

Three months ended

Nine months ended

May 31, 2024

May 31, 2023

May 31, 2024

May 31, 2023

Restricted stock units

261.9

361.2

278.0

361.2

Dividends

The following table sets forth cash dividends declared by the Company to common stockholders during the nine months ended May 31, 2024 and 2023 (in millions, except for per share data):


	Dividend Declaration Date	Dividend per Share		Total of Cash Dividends Declared		Date of Record for Dividend Payment	Dividend Cash Payment Date
Fiscal Year 2024:	October 19, 2023	$	0.08	$	11	November 15, 2023	December 4, 2023
	January 25, 2024	$	0.08	$	10	February 15, 2024	March 4, 2024
	April 17, 2024	$	0.08	$	9	May 15, 2024	June 4, 2024

Fiscal Year 2023:	October 20, 2022	$	0.08	$	12	November 15, 2022	December 2, 2022
	January 26, 2023	$	0.08	$	10	February 15, 2023	March 2, 2023
	April 20, 2023	$	0.08	$	11	May 15, 2023	June 2, 2023

Business Acquisitions and Divestitures	9 Months Ended
Business Acquisitions and Divestitures	May 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Acquisitions and Divestitures	Business Acquisitions and Divestitures Acquisitions On November 1, 2023, the Company completed the acquisition of ProcureAbility Inc. (“ProcureAbility”) for approximately $60 million in cash. ProcureAbility is a procurement services provider specializing in technology-enabled advisory, managed services, digital, staffing, and recruiting solutions. The acquisition of ProcureAbility was accounted for as a business combination using the acquisition method of accounting. Assets acquired of $87 million, including $40 million in intangible assets and $38 million in goodwill, and liabilities assumed of $26 million were recorded at their estimated fair values as of the acquisition date. The preliminary estimates and measurements are subject to change during the measurement period for assets acquired, liabilities assumed and tax adjustments. The excess of the purchase price over the fair value of the acquired assets and assumed liabilities was recorded to goodwill and was fully allocated to the DMS segment. The majority of the goodwill is currently not expected to be deductible for income tax purposes. The results of operations were included in the Company’s condensed consolidated financial results beginning on November 1, 2023. Pro forma information has not been provided as the acquisition of ProcureAbility is not deemed to be significant. Divestitures The Company announced on September 26, 2023 that, through its indirect subsidiary, Jabil Circuit (Singapore) Pte. Ltd., a Singapore private limited company (“Singapore Seller”), it agreed to sell to an affiliate of BYD Electronic (International) Co. Ltd., a Hong Kong limited liability company (“Purchaser” or “BYDE”), its product manufacturing business in Chengdu, including its supporting component manufacturing in Wuxi (the “Business”) for cash consideration of approximately $2.2 billion, subject to certain customary purchase price adjustments. As of August 31, 2023, the Company determined the Business met the criteria to be classified as held for sale. Accordingly, the Company presented the assets and liabilities of the Business as held for sale in the Condensed Consolidated Balance Sheets as of November 30, 2023 and August 31, 2023. Assets and liabilities classified as held for sale had a carrying value less than the estimated fair value less cost to sell and, thus, no adjustment to the carrying value of the disposal group was necessary. Depreciation and amortization expense for long-lived assets was not recorded for the period in which these assets were classified as held for sale. The divestiture did not meet the criteria to be reported as discontinued operations and the Company continued to report the operating results for the Business in the Company’s Condensed Consolidated Statement of Operations in the DMS segment until the Closing Date. On December 29, 2023 (the “Closing Date”), the Company completed the sale. As a result of the transaction, the Company derecognized net assets of approximately $1.2 billion, and recorded a pre-tax gain of $944 million, subject to certain post-closing adjustments that are still being finalized. In addition, the Company agreed to indemnify the Purchaser from certain liabilities that may arise post-close that relate to periods prior to the Closing Date. The Company incurred transaction and disposal costs in connection with the sale of approximately $64 million during the nine months ended May 31, 2024, which are included in continuing operations in the Company’s Condensed Consolidated Statement of Operations. The Company performs a goodwill impairment analysis on an annual basis and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In connection with the preparation of the Company’s financial statements for the quarter ended February 29, 2024, the Company completed an impairment analysis for goodwill recorded within the reporting unit impacted by the divestiture of the Business. The quantitative assessment was used, and the Company determined that it is more likely than not that the fair value of the impacted reporting unit is in excess of the carrying value and that no impairment existed subsequent to the closing of the Business. The Company allocated goodwill to the disposal group based on the relative fair value of the Business as compared to the impacted reporting unit. In the second quarter of fiscal year 2024 and in connection with the divestiture of the Business, the Company made a strategic decision that the indefinite-lived (“Green Point”) trade name valued at $51 million acquired during the acquisition of Green Point should no longer be classified as an indefinite-lived intangible asset. Accordingly, prior to reclassifying the trade name to a finite-lived intangible asset, the Company completed a quantitative assessment for impairment and determined the fair value of the asset exceeded the carrying value. As such, the trade name was assigned a two-year estimated useful life and is being amortized on a straight-line basis as of the Closing Date.

Fair Value Measurements

9 Months Ended

May 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements on a Recurring Basis

The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions):


	Fair Value Hierarchy		May 31, 2024		August 31, 2023
Assets:
Cash and cash equivalents:
Cash equivalents	Level 1	(1)	$	393	$	—
Prepaid expenses and other current assets:
Short-term investments	Level 1		26		25
Forward foreign exchange contracts:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	9		4
Derivatives not designated as hedging instruments (Note 8)	Level 2	(2)	14		20
Net investment hedges:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	8		9




Liabilities:
Accrued expenses:
Forward foreign exchange contracts:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	$	6	$	17
Derivatives not designated as hedging instruments (Note 8)	Level 2	(2)	12		64
Net investment hedges:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	1		1

(1)Consist of time deposits that are readily convertible to cash with original maturities of 90 days or less.

Fair Value of Financial Instruments



			May 31, 2024				August 31, 2023
	Fair Value Hierarchy		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Notes payable and long-term debt: (Note 4)

3.950% Senior Notes	Level 2	(1)	$	498	$	473	$	497	$	468
3.600% Senior Notes	Level 2	(1)	$	497	$	448	$	496	$	448
3.000% Senior Notes	Level 2	(1)	$	594	$	510	$	593	$	502
1.700% Senior Notes	Level 2	(1)	$	498	$	465	$	498	$	452
4.250% Senior Notes	Level 2	(1)	$	496	$	482	$	495	$	478
5.450% Senior Notes	Level 2	(1)	$	296	$	299	$	296	$	297

(1)The fair value estimates are based upon observable market data.

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	May 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Proceedings The Company is party to certain lawsuits in the ordinary course of business. The Company does not believe that these proceedings, individually or in the aggregate, will have a material adverse effect on the Company’s financial position, results of operations or cash flows.

New Accounting Guidance	9 Months Ended
New Accounting Guidance	May 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Guidance	New Accounting Guidance New accounting guidance adopted during the period did not have a material impact to the Company. Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 129	$ 233	$ 1,250	$ 663

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	May 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

New Accounting Guidance (Policies)	9 Months Ended
New Accounting Guidance (Policies)	May 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Guidance	New accounting guidance adopted during the period did not have a material impact to the Company. Recently issued accounting guidance is not applicable or did not have, or is not expected to have, a material impact to the Company.

Trade Accounts Receivable Sale Programs (Tables)

9 Months Ended

May 31, 2024

Transfers and Servicing [Abstract]

Schedule of Trade Accounts Receivable Sale Programs Amounts Recognized

In connection with the trade accounts receivable sale programs, the Company recognized the following (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Trade accounts receivable sold(1)	$	2,126	$	2,594	$	5,980	$	9,044
Cash proceeds received	$	2,113	$	2,583	$	5,947	$	9,015
Pre-tax losses on sale of receivables(2)	$	13	$	11	$	33	$	29

(2)Recorded to other expense within the Condensed Consolidated Statements of Operations.

Inventories (Tables)

9 Months Ended

May 31, 2024

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consist of the following (in millions):


	May 31, 2024		August 31, 2023(1)
Raw materials	$	4,104	$	4,804
Work in process	197		217
Finished goods	190		243
Reserve for excess and obsolete inventory	(52)		(58)
Inventories, net	$	4,439	$	5,206

(1)Excludes $559 million of inventories, net classified as held for sale as of August 31, 2023. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

Notes Payable and Long-Term Debt (Tables)

9 Months Ended

May 31, 2024

Debt Disclosure [Abstract]

Schedule of Notes Payable and Long-term Debt

Notes payable and long-term debt outstanding as of May 31, 2024 and August 31, 2023 are summarized below (in millions):


	Maturity Date	May 31, 2024		August 31, 2023

3.950% Senior Notes	Jan 12, 2028	$	498	$	497
3.600% Senior Notes	Jan 15, 2030	497		496
3.000% Senior Notes	Jan 15, 2031	594		593
1.700% Senior Notes	Apr 15, 2026	498		498
4.250% Senior Notes	May 15, 2027	496		495
5.450% Senior Notes	Feb 1, 2029	296		296
Borrowings under credit facilities(1)(2)	Jan 22, 2026 and Jan 22, 2028	—		—
Borrowings under loans	Jul 31, 2026	—		—
Total notes payable and long-term debt		2,879		2,875
Less current installments of notes payable and long-term debt		—		—
Notes payable and long-term debt, less current installments		$	2,879	$	2,875

Asset-Backed Securitization Program (Tables)

9 Months Ended

May 31, 2024

Transfers and Servicing [Abstract]

Schedule of Asset-backed Securitization Programs Amounts Recognized

In connection with the asset-backed securitization program, the Company recognized the following (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Trade accounts receivable sold(1)	$	1,006	$	1,007	$	2,965	$	3,071
Cash proceeds received(2)	$	994	$	996	$	2,931	$	3,043

Pre-tax losses on sale of receivables(3)	$	12	$	11	$	34	$	28

(2)The amounts primarily represent proceeds from collections reinvested in revolving-period transfers.

(3)Recorded to other expense within the Condensed Consolidated Statements of Operations.

Accrued Expenses (Tables)

9 Months Ended

May 31, 2024

Accrued Liabilities, Current [Abstract]

Schedule of Accrued Expenses

Accrued expenses consist of the following (in millions):


	May 31, 2024		August 31, 2023(2)
Inventory deposits	$	1,564	$	1,839
Contract liabilities(1)	977		886
Accrued compensation and employee benefits	635		743


Other accrued expenses	2,753		2,047
Accrued expenses	$	5,929	$	5,515

(2)Excludes $364 million of accrued expenses classified as held for sale as of August 31, 2023. See Note 15 – “Business Acquisitions and Divestitures” for additional information.

Postretirement and Other Employee Benefits (Tables)

9 Months Ended

May 31, 2024

Retirement Benefits [Abstract]

Schedule of Information about Net Periodic Benefit Cost

The following table provides information about the net periodic benefit cost for all plans for the three months and nine months ended May 31, 2024 and 2023 (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Service cost(1)	$	5	$	4	$	15	$	12
Interest cost(2)	3		3		9		9
Expected long-term return on plan assets(2)	(4)		(4)		(13)		(12)
Recognized actuarial gain(2)	(1)		(2)		(4)		(6)
Amortization of actuarial gain(2)(3)	(2)		(2)		(4)		(5)

Amortization of prior service cost(2)	1		1		3		3
Net periodic benefit cost	$	2	$	—	$	6	$	1

(1)Service cost is recognized in cost of revenue in the Condensed Consolidated Statements of Operations.

(2)Components are recognized in other expense in the Condensed Consolidated Statements of Operations.

Derivative Financial Instruments and Hedging Activities (Tables)

9 Months Ended

May 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Maturity Date and Aggregate Notional Amount Outstanding of Net Investment Hedges

The maturity dates and aggregate notional amount outstanding of net investment hedges are as follows (in millions):


Maturity date	May 31, 2024		August 31, 2023
September 2023	$	—	$	34
October 2023	—		96
January 2024	—		96
April 2024	—		68
July 2024	176		102
October 2024	115		—
January 2025	101		—
Total	$	392	$	396

Schedule of Net Gains (Losses) from Forward Contracts Recorded in Consolidated Statements of Operations

The following table presents the net gains (losses) from forward contracts recorded in the Condensed Consolidated Statements of Operations for the periods indicated (in millions):


Derivatives Not Designated as Hedging Instruments Under ASC 815	Location of Gain (Loss) on Derivatives Recognized in Net Income	Amount of Gain (Loss) Recognized in Net Income on Derivatives
		Three months ended				Nine months ended
		May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Forward foreign exchange contracts(1)	Cost of revenue	$	—	$	(41)	$	7	$	(57)

Accumulated Other Comprehensive Income (Tables)

9 Months Ended

May 31, 2024

Equity [Abstract]

Schedule of Changes in AOCI

The following table sets forth the changes in AOCI, net of tax, by component for the nine months ended May 31, 2024 (in millions):


	Foreign Currency Translation Adjustment		Net Investment Hedges		Derivative Instruments		Actuarial Gain (Loss)		Prior Service (Cost) Credit		Total
Balance as of August 31, 2023	$	(59)	$	(4)	$	14	$	46	$	(14)	$	(17)
Other comprehensive (loss) income before reclassifications	(5)		5		(4)		—		—		(4)

Amounts reclassified from AOCI	(2)		(4)		13		(7)		3		3
Other comprehensive (loss) income(1)	(7)		1		9		(7)		3		(1)
Balance as of May 31, 2024	$	(66)	$	(3)	$	23	$	39	$	(11)	$	(18)

(1)Amounts are net of tax, which are immaterial.

Schedule of Reclassification from AOCI


		Three months ended				Nine months ended
Comprehensive Income Components	Financial Statement Line Item	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Realized gains on foreign currency translation	Gain from the divestiture of businesses	$	—	$	—	$	(2)	$	—
Realized gains on net investment hedges	Gain from the divestiture of businesses	—		—		(4)		—
Realized (gains) losses on derivative instruments:(1)
Foreign exchange contracts	Cost of revenue	—		(7)		15		37
Interest rate contracts	Interest expense, net	(1)		(1)		(2)		(1)
Realized (gains) losses on pension and postretirement plans:
Actuarial gains	(2)	(2)		(4)		(7)		(11)
Prior service costs	(2)	1		1		3		3
Total amounts reclassified from AOCI(3)		$	(2)	$	(11)	$	3	$	28

(1)The Company expects to reclassify $3 million into earnings during the next twelve months, which will primarily be classified as a component of cost of revenue.

(2)Amounts are included in the computation of net periodic benefit cost. Refer to Note 7 – “Postretirement and Other Employee Benefits” for additional information.

(3)Amounts are net of tax, which are immaterial for the three months and nine months ended May 31, 2024 and 2023.

Stockholders' Equity (Tables)

9 Months Ended

May 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Recognized Stock-based Compensation Expense

The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Restricted stock units(1)	$	(2)	$	14	$	58	$	68
Employee stock purchase plan	5		4		14		12

Total	$	3	$	18	$	72	$	80

Schedule of Share-based Compensation Information

The following represents the stock-based compensation information as of the period indicated (in millions):


	May 31, 2024
Unrecognized stock-based compensation expense – restricted stock units	$	55
Remaining weighted-average period for restricted stock units expense	1.5 years

Schedule of Common Stock Outstanding

The following represents the common stock outstanding for the periods indicated:


	Three months ended		Nine months ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Common stock outstanding:
Beginning balances	122,440,607	133,238,368	131,294,422	135,493,980

Shares issued under employee stock purchase plan	—	1,730	338,316	631,066
Vesting of restricted stock	21,550	3,372	1,791,066	2,013,768
Purchases of treasury stock under employee stock plans	(7,512)	(700)	(534,335)	(571,349)
Treasury shares purchased(1)(2)	(3,733,966)	(1,890,906)	(14,168,790)	(6,215,601)
Ending balances	118,720,679	131,351,864	118,720,679	131,351,864

Concentration of Risk and Segment Data (Tables)

9 Months Ended

May 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Income

The following table sets forth operating segment information (in millions):


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
Segment income and reconciliation of income before income tax
EMS	$	195	$	226	$	505	$	629
DMS	155		178		682		627
Total segment income	$	350	$	404	$	1,187	$	1,256
Reconciling items:
Amortization of intangibles	(12)		(7)		(27)		(24)
Stock-based compensation expense and related charges	(3)		(18)		(72)		(80)
Restructuring, severance and related charges(1)	(55)		—		(252)		(45)

Business interruption and impairment charges, net(2)	(14)		—		(14)		—


Gain from the divestiture of businesses(3)	—		—		944		—
Acquisition and divestiture related charges(3)	(3)		—		(64)		—
Other expense (net of periodic benefit cost)	(24)		(22)		(72)		(61)
Interest expense, net	(38)		(51)		(132)		(154)
Income before income tax	$	201	$	306	$	1,498	$	892

Schedule of Revenues Disaggregated by Segment

The following table presents the Company’s revenues disaggregated by segment (in millions):


	Three months ended
	May 31, 2024						May 31, 2023
	EMS		DMS		Total		EMS		DMS		Total
Timing of transfer
Point in time	$	1,172	$	559	$	1,731	$	1,120	$	1,351	$	2,471
Over time	2,225		2,809		5,034		3,010		2,994		6,004
Total	$	3,397	$	3,368	$	6,765	$	4,130	$	4,345	$	8,475


	Nine months ended
	May 31, 2024						May 31, 2023
	EMS		DMS		Total		EMS		DMS		Total
Timing of transfer
Point in time	$	3,473	$	3,346	$	6,819	$	3,925	$	5,047	$	8,972
Over time	6,847		8,253		15,100		8,802		8,470		17,272
Total	$	10,320	$	11,599	$	21,919	$	12,727	$	13,517	$	26,244

Schedule of Foreign Source Revenue

The following table sets forth, for the periods indicated, foreign source revenue expressed as a percentage of net revenue:


	Three months ended				Nine months ended
	May 31, 2024(1)		May 31, 2023		May 31, 2024(1)		May 31, 2023
Foreign source revenue	80.5	%	86.9	%	83.4	%	85.6	%

(1)Decrease from prior periods is driven by the divestiture of the mobility business during the three months ended February 29, 2024.

Restructuring, Severance and Related Charges (Tables)

9 Months Ended

May 31, 2024

Restructuring and Related Activities [Abstract]

Schedule of Restructuring, Severance and Related Charges and Liability Activity

Following is a summary of the Company’s restructuring, severance and related charges (in millions):


	Three months ended				Nine months ended
	May 31, 2024(1)		May 31, 2023(2)		May 31, 2024(1)		May 31, 2023(2)
Employee severance and benefit costs	$	33	$	—	$	156	$	36
Lease costs	1		—		2		—
Asset write-off costs	17		—		72		5
Other costs	4		—		22		4
Total restructuring, severance and related charges(3)	$	55	$	—	$	252	$	45

(1)Primarily relates to the 2024 Restructuring Plan.

(2)Primarily relates to headcount reduction to further optimize the Company’s business activities.

The table below summarizes the Company’s liability activity, primarily associated with the 2024 Restructuring Plan (in millions):


	Employee Severance and Benefit Costs		Lease Costs		Asset Write-off Costs		Other Related Costs		Total
Balance as of August 31, 2023	$	—	$	—	$	—	$	—	$	—
Restructuring related charges	156		2		72		22		252
Asset write-off charge and other non-cash activity	2		—		(72)		(5)		(75)
Cash payments	(91)		(1)		—		(9)		(101)
Balance as of May 31, 2024	$	67	$	1	$	—	$	8	$	76

Income Taxes (Tables)

9 Months Ended

May 31, 2024

Income Tax Disclosure [Abstract]

Schedule of U.S. Federal Statutory Income Tax Rate Compared to Actual Income Tax Expense

The U.S. federal statutory income tax rate and the Company's effective income tax rate are as follows:


	Three months ended				Nine months ended
	May 31, 2024		May 31, 2023		May 31, 2024		May 31, 2023
U.S. federal statutory income tax rate	21.0	%	21.0	%	21.0	%	21.0	%
Effective income tax rate	35.7	%	24.0	%	16.6	%	25.7	%

Earnings Per Share and Dividends (Tables)

9 Months Ended

May 31, 2024

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands):

Three months ended

Nine months ended

May 31, 2024

May 31, 2023

May 31, 2024

May 31, 2023

Restricted stock units

261.9

361.2

278.0

361.2

Schedule of Cash Dividends Declared by the Company to Common Stockholders

The following table sets forth cash dividends declared by the Company to common stockholders during the nine months ended May 31, 2024 and 2023 (in millions, except for per share data):


	Dividend Declaration Date	Dividend per Share		Total of Cash Dividends Declared		Date of Record for Dividend Payment	Dividend Cash Payment Date
Fiscal Year 2024:	October 19, 2023	$	0.08	$	11	November 15, 2023	December 4, 2023
	January 25, 2024	$	0.08	$	10	February 15, 2024	March 4, 2024
	April 17, 2024	$	0.08	$	9	May 15, 2024	June 4, 2024

Fiscal Year 2023:	October 20, 2022	$	0.08	$	12	November 15, 2022	December 2, 2022
	January 26, 2023	$	0.08	$	10	February 15, 2023	March 2, 2023
	April 20, 2023	$	0.08	$	11	May 15, 2023	June 2, 2023

Fair Value Measurements (Tables)

9 Months Ended

May 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value of Financial Assets and Liabilities

The following table presents the fair value of the Company's financial assets and liabilities measured at fair value by hierarchy level on a recurring basis as of the periods indicated (in millions):


	Fair Value Hierarchy		May 31, 2024		August 31, 2023
Assets:
Cash and cash equivalents:
Cash equivalents	Level 1	(1)	$	393	$	—
Prepaid expenses and other current assets:
Short-term investments	Level 1		26		25
Forward foreign exchange contracts:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	9		4
Derivatives not designated as hedging instruments (Note 8)	Level 2	(2)	14		20
Net investment hedges:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	8		9




Liabilities:
Accrued expenses:
Forward foreign exchange contracts:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	$	6	$	17
Derivatives not designated as hedging instruments (Note 8)	Level 2	(2)	12		64
Net investment hedges:
Derivatives designated as hedging instruments (Note 8)	Level 2	(2)	1		1

(1)Consist of time deposits that are readily convertible to cash with original maturities of 90 days or less.

Schedule of Carrying Amounts and Fair Values of Notes Payable and Long-term Debt

The following table presents the carrying amounts and fair values of the Company's notes payable and long-term debt, by hierarchy level as of the periods indicated (in millions):



			May 31, 2024				August 31, 2023
	Fair Value Hierarchy		Carrying Amount		Fair Value		Carrying Amount		Fair Value
Notes payable and long-term debt: (Note 4)

3.950% Senior Notes	Level 2	(1)	$	498	$	473	$	497	$	468
3.600% Senior Notes	Level 2	(1)	$	497	$	448	$	496	$	448
3.000% Senior Notes	Level 2	(1)	$	594	$	510	$	593	$	502
1.700% Senior Notes	Level 2	(1)	$	498	$	465	$	498	$	452
4.250% Senior Notes	Level 2	(1)	$	496	$	482	$	495	$	478
5.450% Senior Notes	Level 2	(1)	$	296	$	299	$	296	$	297

(1)The fair value estimates are based upon observable market data.

Trade Accounts Receivable Sale Programs - Additional Information (Details) - 9 months ended May 31, 2024	USD ($) program	CHF (SFr)	INR (₨)	CNY (¥)
USD
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount \| $	$ 1,900,000,000
Number of programs	9
CHF
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount \| SFr		SFr 100,000,000
Number of programs	1
INR
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount \| ₨			₨ 8,100,000,000
Number of programs	1
CNY
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Maximum amount \| ¥				¥ 1,900,000,000
Number of programs	1

Trade Accounts Receivable Sale Programs - Trade Accounts Receivable Sale Programs Amounts Recognized (Details) - Trade Accounts Receivable Sale Programs - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Trade accounts receivable sold	$ 2,126	$ 2,594	$ 5,980	$ 9,044
Cash proceeds received	2,113	2,583	5,947	9,015
Pre-tax losses on sale of receivables	$ 13	$ 11	$ 33	$ 29

Inventories (Details) - USD ($) $ in Millions	May 31, 2024	Aug. 31, 2023
Inventory [Line Items]
Raw materials	$ 4,104	$ 4,804
Work in process	197	217
Finished goods	190	243
Reserve for excess and obsolete inventory	(52)	(58)
Inventories, net	$ 4,439	5,206
Product Manufacturing Business \| Held for sale
Inventory [Line Items]
Inventories, net classified as held for sale		$ 559

Notes Payable and Long-Term Debt - Schedule of Notes Payable and Long-term Debt (Details) - USD ($)	Feb. 23, 2024	May 31, 2024	Aug. 31, 2023
Debt Instrument [Line Items]
Total notes payable and long-term debt		$ 2,879,000,000	$ 2,875,000,000
Less current installments of notes payable and long-term debt		0	0
Notes payable and long-term debt, less current installments		$ 2,879,000,000	2,875,000,000
Senior Notes \| 3.950% Senior Notes
Debt Instrument [Line Items]
Stated interest rate		3.95%
Total notes payable and long-term debt		$ 498,000,000	497,000,000
Senior Notes \| 3.600% Senior Notes
Debt Instrument [Line Items]
Stated interest rate		3.60%
Total notes payable and long-term debt		$ 497,000,000	496,000,000
Senior Notes \| 3.000% Senior Notes
Debt Instrument [Line Items]
Stated interest rate		3.00%
Total notes payable and long-term debt		$ 594,000,000	593,000,000
Senior Notes \| 1.700% Senior Notes
Debt Instrument [Line Items]
Stated interest rate		1.70%
Total notes payable and long-term debt		$ 498,000,000	498,000,000
Senior Notes \| 4.250% Senior Notes
Debt Instrument [Line Items]
Stated interest rate		4.25%
Total notes payable and long-term debt		$ 496,000,000	495,000,000
Senior Notes \| 5.450% Senior Notes
Debt Instrument [Line Items]
Stated interest rate		5.45%
Total notes payable and long-term debt		$ 296,000,000	296,000,000
Line of Credit \| Revolving Credit Facility
Debt Instrument [Line Items]
Total notes payable and long-term debt		0	0
Available unused borrowing capacity		4,000,000,000
Line of Credit \| Revolving Credit Facility \| Credit Facility Due
Debt Instrument [Line Items]
Debt term	1 year
Line of Credit \| Revolving Credit Facility \| Credit Facility Due January 2026
Debt Instrument [Line Items]
Debt term	3 years
Line of Credit \| Revolving Credit Facility \| Credit Facility Due January 2028
Debt Instrument [Line Items]
Debt term	5 years
Line of Credit \| Term Loan Facility
Debt Instrument [Line Items]
Total notes payable and long-term debt		0	$ 0
Line of Credit \| Commercial Paper
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 3,200,000,000

Notes Payable and Long-Term Debt - Additional Information (Details) - Senior Notes	May 31, 2024
3.950% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.95%
3.600% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.60%
3.000% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	3.00%
1.700% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	1.70%
4.250% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	4.25%
5.450% Senior Notes
Debt Instrument [Line Items]
Stated interest rate	5.45%

Asset-Backed Securitization Program - Additional Information (Details) - USD ($)	May 31, 2024	Feb. 20, 2024	Feb. 19, 2024
Transfers and Servicing [Abstract]
Maximum amount of net cash proceeds		$ 700,000,000	$ 600,000,000
Available liquidity under its asset-backed securitization programs (up to)	$ 0

Asset-Backed Securitization Program - Securitization Activity (Details) - Asset-Backed Securitization Program - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Trade Accounts Receivable Securitization and Sale Program [Line Items]
Trade accounts receivable sold	$ 1,006	$ 1,007	$ 2,965	$ 3,071
Cash proceeds received	994	996	2,931	3,043
Pre-tax losses on sale of receivables	$ 12	$ 11	$ 34	$ 28

Accrued Expenses (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Accrued Expenses (Details) - USD ($) $ in Millions	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023	Aug. 31, 2023
Supplier Finance Program [Line Items]
Inventory deposits	$ 1,564		$ 1,564		$ 1,839
Contract liabilities	977		977		886
Accrued compensation and employee benefits	635		635		743
Other accrued expenses	2,753		2,753		2,047
Accrued expenses	5,929		5,929		5,515
Revenue recognized during period that was included in contract liability balance	$ 116	$ 99	$ 391	$ 353
Held for sale \| Product Manufacturing Business
Supplier Finance Program [Line Items]
Accrued expenses classified as held for sale					$ 364

Postretirement and Other Employee Benefits (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Retirement Benefits [Abstract]
Service cost	$ 5	$ 4	$ 15	$ 12
Interest cost	3	3	9	9
Expected long-term return on plan assets	(4)	(4)	(13)	(12)
Recognized actuarial gain	(1)	(2)	(4)	(6)
Amortization of actuarial gain	(2)	(2)	(4)	(5)
Amortization of prior service cost	1	1	3	3
Net periodic benefit cost	$ 2	$ 0	$ 6	$ 1
Percentage of gain (loss) corridor	10.00%		10.00%

Derivative Financial Instruments and Hedging Activities - Additional Information (Details) - Forward contracts - Forward foreign exchange contracts - Cash flow hedging - USD ($) $ in Millions	May 31, 2024	Aug. 31, 2023
Designated as hedging instruments
Derivative [Line Items]
Aggregate notional amount	$ 283	$ 491
Not designated as hedging instruments
Derivative [Line Items]
Aggregate notional amount	$ 2,500	$ 4,000

Derivative Financial Instruments and Hedging Activities - Schedule of Maturity Date and Aggregate Notional Amount Outstanding of Net Investment Hedges (Details) - Net investment hedges - Forward contracts - Designated as hedging instruments - USD ($) $ in Millions	May 31, 2024	Aug. 31, 2023
September 2023
Derivative [Line Items]
Aggregate notional amount	$ 0	$ 34
October 2023
Derivative [Line Items]
Aggregate notional amount	0	96
January 2024
Derivative [Line Items]
Aggregate notional amount	0	96
April 2024
Derivative [Line Items]
Aggregate notional amount	0	68
July 2024
Derivative [Line Items]
Aggregate notional amount	176	102
October 2024
Derivative [Line Items]
Aggregate notional amount	115	0
January 2025
Derivative [Line Items]
Aggregate notional amount	101	0
Foreign exchange contracts
Derivative [Line Items]
Aggregate notional amount	$ 392	$ 396

Derivative Financial Instruments and Hedging Activities - Fair Value of Derivative Instruments Recorded on Consolidated Statements of Operations (Details) - Forward foreign exchange contracts - Cost of revenue - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Net Income on Derivatives	$ 0	$ (41)	$ 7	$ (57)
Foreign currency gains (losses)	$ (1)	$ 24	$ (36)	$ 20

Accumulated Other Comprehensive Income - Change in AOCI, Net of Tax (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	$ 2,658	$ 2,674	$ 2,867	$ 2,452
Other comprehensive (loss) income before reclassifications			(4)
Amounts reclassified from AOCI			3
Total other comprehensive (loss) income	(1)	(20)	(1)	31
Ending Balance	2,276	2,737	2,276	2,737
AOCI Attributable to Parent
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance	(17)	9	(17)	(42)
Total other comprehensive (loss) income	(1)	(20)	(1)	31
Ending Balance	(18)	$ (11)	(18)	$ (11)
Foreign Currency Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			(59)
Other comprehensive (loss) income before reclassifications			(5)
Amounts reclassified from AOCI			(2)
Total other comprehensive (loss) income			(7)
Ending Balance	(66)		(66)
Net Investment Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			(4)
Other comprehensive (loss) income before reclassifications			5
Amounts reclassified from AOCI			(4)
Total other comprehensive (loss) income			1
Ending Balance	(3)		(3)
Derivative Instruments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			14
Other comprehensive (loss) income before reclassifications			(4)
Amounts reclassified from AOCI			13
Total other comprehensive (loss) income			9
Ending Balance	23		23
Actuarial Gain (Loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			46
Other comprehensive (loss) income before reclassifications			0
Amounts reclassified from AOCI			(7)
Total other comprehensive (loss) income			(7)
Ending Balance	39		39
Prior Service (Cost) Credit
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning Balance			(14)
Other comprehensive (loss) income before reclassifications			0
Amounts reclassified from AOCI			3
Total other comprehensive (loss) income			3
Ending Balance	$ (11)		$ (11)

Accumulated Other Comprehensive Income - Reclassification from AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Gain from the divestiture of businesses	$ 0	$ 0	$ (944)	$ 0
Cost of revenue	6,157	7,778	19,906	24,143
Other expense (income)	22	18	65	50
Total amounts reclassified from AOCI	(129)	(233)	(1,250)	(663)
Reclassified in next 12 months (less than)			3
Reclassification out of AOCI
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Total amounts reclassified from AOCI	(2)	(11)	3	28
Reclassification out of AOCI \| Foreign Currency Translation Adjustment
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Gain from the divestiture of businesses	0	0	(2)	0
Reclassification out of AOCI \| Net Investment Hedges
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Gain from the divestiture of businesses	0	0	(4)	0
Reclassification out of AOCI \| Realized (gains) losses on derivative instruments \| Foreign exchange contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Cost of revenue	0	(7)	15	37
Reclassification out of AOCI \| Realized (gains) losses on derivative instruments \| Interest rate contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Interest rate contracts	(1)	(1)	(2)	(1)
Reclassification out of AOCI \| Actuarial gains
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other expense (income)	(2)	(4)	(7)	(11)
Reclassification out of AOCI \| Prior service costs
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other expense (income)	$ 1	$ 1	$ 3	$ 3

Stockholders' Equity - Recognized Stock-Based Compensation (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	$ 3	$ 18	$ 72	$ 80
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	(2)	14	58	68
Reversal of stock-based compensation expense	13
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total	$ 5	$ 4	$ 14	$ 12

Stockholders' Equity - Additional Information (Details) - USD ($)	1 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2024	May 31, 2024	May 31, 2023	Aug. 31, 2023	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payments for repurchase of common stock		$ 1,824,000,000	$ 442,000,000
2023 Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Value of shares repurchased		$ 1,800,000,000		$ 224,000,000
Stock repurchase program, authorized amount					$ 2,500,000,000	$ 1,000,000,000
2023 Share Repurchase Program \| Subsequent event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Value of shares repurchased	$ 121,000,000
Accelerated Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount					$ 500,000,000
Accelerated Share Repurchase Program \| Subsequent event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount	555,000,000
Payments for repurchase of common stock	$ 555,000,000
Time-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		3 years
Restricted stock units awarded (in shares)		500,000	900,000
Performance-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		3 years
Restricted stock units awarded (in shares)		100,000	200,000
Performance-based restricted stock units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		150.00%
Market-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		3 years
Restricted stock units awarded (in shares)		100,000	200,000
Market-based restricted stock units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		200.00%
2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available to be issued (in shares)		8,059,728

Stockholders' Equity - Stock-based Compensation Information (Details) $ in Millions	9 Months Ended
	May 31, 2024 USD ($)
Share-Based Payment Arrangement [Abstract]
Unrecognized stock-based compensation expense – restricted stock units	$ 55
Remaining weighted-average period for restricted stock units expense	1 year 6 months

Stockholders' Equity - Common Stock Outstanding (Details) - USD ($)	3 Months Ended			9 Months Ended		12 Months Ended	20 Months Ended
	May 31, 2024	Nov. 30, 2023	May 31, 2023	May 31, 2024	May 31, 2023	Aug. 31, 2023	Feb. 28, 2023	Sep. 30, 2023	Sep. 30, 2022	Jul. 31, 2021
Common stock outstanding:
Common stock outstanding, beginning balances (in shares)		131,294,422		131,294,422
Common stock outstanding, ending balance (in shares)	118,720,679			118,720,679		131,294,422
2022 Share Repurchase Program
Common stock outstanding:
Share repurchase program, amount authorized										$ 1,000,000,000
Number of shares repurchased (in shares)							16,500,000
Value of shares repurchased							$ 1,000,000,000
Share repurchase program, remaining amount available							$ 0
2023 Share Repurchase Program
Common stock outstanding:
Share repurchase program, amount authorized								$ 2,500,000,000	$ 1,000,000,000
Number of shares repurchased (in shares)				14,200,000		2,700,000
Value of shares repurchased				$ 1,800,000,000		$ 224,000,000
Share repurchase program, remaining amount available	$ 676,000,000			$ 676,000,000
Accelerated Share Repurchase Program
Common stock outstanding:
Share repurchase program, amount authorized								$ 500,000,000
Number of shares repurchased (in shares)		3,900,000
Average price (in usd per share)		$ 128.61
Common stock:
Common stock outstanding:
Common stock outstanding, beginning balances (in shares)	122,440,607	131,294,422	133,238,368	131,294,422	135,493,980	135,493,980
Shares issued under employee stock purchase plan (in shares)	0		1,730	338,316	631,066
Vesting of restricted stock (in shares)	21,550		3,372	1,791,066	2,013,768
Purchases of treasury stock under employee stock plans (in shares)	(7,512)		(700)	(534,335)	(571,349)
Treasury shares purchased (in shares)	(3,733,966)		(1,890,906)	(14,168,790)	(6,215,601)
Common stock outstanding, ending balance (in shares)	118,720,679		131,351,864	118,720,679	131,351,864	131,294,422	133,238,368

Concentration of Risk and Segment Data - Additional Information (Details)	9 Months Ended
	May 31, 2024 country
Revenue, Major Customer [Line Items]
Number of operating countries (more than)	30
Five Largest Customers \| Net revenue \| Customer Concentration
Revenue, Major Customer [Line Items]
Concentration risk	37.00%
Eighty Six Customers \| Net revenue \| Customer Concentration
Revenue, Major Customer [Line Items]
Concentration risk	90.00%

Concentration of Risk and Segment Data - Segment Income (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
	Dec. 29, 2023	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income		$ 201	$ 306	$ 1,498	$ 892
Reconciling items:
Amortization of intangibles		(12)	(7)	(27)	(24)
Stock-based compensation expense and related charges		(3)	(18)	(72)	(80)
Restructuring, severance and related charges		(55)	0	(252)	(45)
Gain from the divestiture of businesses		0	0	944	0
Acquisition and divestiture related charges		(3)	0	(64)	0
Held for sale \| Product Manufacturing Business
Reconciling items:
Gain from the divestiture of businesses	$ 944			944
Transaction, exit and disposal costs				64
Operating Segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income		350	404	1,187	1,256
Operating Segments \| EMS
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income		195	226	505	629
Reconciling items:
Restructuring, severance and related charges		(23)	0	(63)	(4)
Operating Segments \| DMS
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income		155	178	682	627
Reconciling items:
Restructuring, severance and related charges		(15)	0	(129)	(33)
Segment Reconciling Items
Reconciling items:
Amortization of intangibles		(12)	(7)	(27)	(24)
Stock-based compensation expense and related charges		(3)	(18)	(72)	(80)
Restructuring, severance and related charges		(55)	0	(252)	(45)
Business interruption and impairment charges, net		(14)	0	(14)	0
Gain from the divestiture of businesses		0	0	944	0
Acquisition and divestiture related charges		(3)	0	(64)	0
Other expense (net of periodic benefit cost)		(24)	(22)	(72)	(61)
Interest expense, net		$ (38)	$ (51)	$ (132)	$ (154)

Concentration of Risk and Segment Data - Revenues Disaggregated by Segment (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Disaggregation of Revenue [Line Items]
Net revenue	$ 6,765	$ 8,475	$ 21,919	$ 26,244
Point in time
Disaggregation of Revenue [Line Items]
Net revenue	1,731	2,471	6,819	8,972
Over time
Disaggregation of Revenue [Line Items]
Net revenue	5,034	6,004	15,100	17,272
EMS
Disaggregation of Revenue [Line Items]
Net revenue	3,397	4,130	10,320	12,727
EMS \| Point in time
Disaggregation of Revenue [Line Items]
Net revenue	1,172	1,120	3,473	3,925
EMS \| Over time
Disaggregation of Revenue [Line Items]
Net revenue	2,225	3,010	6,847	8,802
DMS
Disaggregation of Revenue [Line Items]
Net revenue	3,368	4,345	11,599	13,517
DMS \| Point in time
Disaggregation of Revenue [Line Items]
Net revenue	559	1,351	3,346	5,047
DMS \| Over time
Disaggregation of Revenue [Line Items]
Net revenue	$ 2,809	$ 2,994	$ 8,253	$ 8,470

Concentration of Risk and Segment Data - Foreign Source Revenue (Details)	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Foreign source revenue \| Net revenue \| Foreign source revenue
Concentration Risk [Line Items]
Concentration risk	80.50%	86.90%	83.40%	85.60%

Restructuring, Severance and Related Charges - Schedule of Restructuring, Severance and Related Charges (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	$ 55	$ 0	$ 252	$ 45
Operating Segments \| EMS
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	23	0	63	4
Operating Segments \| DMS
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	15	0	129	33
Non-allocated charges
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	17	0	60	8
Employee severance and benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	33	0	156	36
Asset write-off costs
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	17	0	72	5
Other costs
Restructuring Cost and Reserve [Line Items]
Restructuring, severance and related charges	$ 4	$ 0	$ 22	$ 4

Restructuring, Severance and Related Charges - Additional Information (Details) - 2024 Restructuring Plan $ in Millions	May 31, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Total pre-tax restructuring and other related costs expected to be recognized	$ 300
Employee severance and benefit costs \| Minimum
Restructuring Cost and Reserve [Line Items]
Total pre-tax restructuring and other related costs expected to be recognized	150
Employee severance and benefit costs \| Maximum
Restructuring Cost and Reserve [Line Items]
Total pre-tax restructuring and other related costs expected to be recognized	180
Asset write-off costs \| Minimum
Restructuring Cost and Reserve [Line Items]
Total pre-tax restructuring and other related costs expected to be recognized	80
Asset write-off costs \| Maximum
Restructuring Cost and Reserve [Line Items]
Total pre-tax restructuring and other related costs expected to be recognized	120
Contract Termination \| Minimum
Restructuring Cost and Reserve [Line Items]
Total pre-tax restructuring and other related costs expected to be recognized	30
Contract Termination \| Maximum
Restructuring Cost and Reserve [Line Items]
Total pre-tax restructuring and other related costs expected to be recognized	$ 40

Restructuring, Severance and Related Charges - Liability Activity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Restructuring Reserve [Roll Forward]
Restructuring related charges	$ 55	$ 0	$ 252	$ 45
Employee Severance and Benefit Costs
Restructuring Reserve [Roll Forward]
Restructuring related charges	33	0	156	36
Lease Costs
Restructuring Reserve [Roll Forward]
Restructuring related charges	1	0	2	0
Asset Write-off Costs
Restructuring Reserve [Roll Forward]
Restructuring related charges	17	0	72	5
Other Related Costs
Restructuring Reserve [Roll Forward]
Restructuring related charges	4	$ 0	22	$ 4
2024 Restructuring Plan
Restructuring Reserve [Roll Forward]
Beginning balance			0
Restructuring related charges			252
Asset write-off charge and other non-cash activity			(75)
Cash payments			(101)
Ending balance	76		76
2024 Restructuring Plan \| Employee Severance and Benefit Costs
Restructuring Reserve [Roll Forward]
Beginning balance			0
Restructuring related charges			156
Asset write-off charge and other non-cash activity			2
Cash payments			(91)
Ending balance	67		67
2024 Restructuring Plan \| Lease Costs
Restructuring Reserve [Roll Forward]
Beginning balance			0
Restructuring related charges			2
Asset write-off charge and other non-cash activity			0
Cash payments			(1)
Ending balance	1		1
2024 Restructuring Plan \| Asset Write-off Costs
Restructuring Reserve [Roll Forward]
Beginning balance			0
Restructuring related charges			72
Asset write-off charge and other non-cash activity			(72)
Cash payments			0
Ending balance	0		0
2024 Restructuring Plan \| Other Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance			0
Restructuring related charges			22
Asset write-off charge and other non-cash activity			(5)
Cash payments			(9)
Ending balance	$ 8		$ 8

Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate Compared to Actual Income Tax Expense (Details)	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Income Tax Disclosure [Abstract]
U.S. federal statutory income tax rate	21.00%	21.00%	21.00%	21.00%
Effective income tax rate	35.70%	24.00%	16.60%	25.70%

Income Taxes - Additional Information (Details) $ in Millions	3 Months Ended
	Feb. 29, 2024 USD ($)
Income Tax Disclosure [Abstract]
Gain on divestiture of the mobility business	$ 58

Earnings Per Share and Dividends - Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	May 31, 2024	May 31, 2023	May 31, 2024	May 31, 2023
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common shares excluded from computation of diluted earnings per share (in shares)	261,900	361,200	278,000.0	361,200

Earnings Per Share and Dividends - Cash Dividends Declared by the Company to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Millions	Apr. 17, 2024	Jan. 25, 2024	Oct. 19, 2023	Apr. 20, 2023	Jan. 26, 2023	Oct. 20, 2022
Earnings Per Share [Abstract]
Dividends per Share (in usd per share)	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08	$ 0.08
Total of Cash Dividends Declared	$ 9	$ 10	$ 11	$ 11	$ 10	$ 12

Business Acquisitions and Divestitures (Details) - USD ($) $ in Millions			3 Months Ended			9 Months Ended
	Dec. 29, 2023	Nov. 01, 2023	May 31, 2024	Feb. 29, 2024	May 31, 2023	May 31, 2024	May 31, 2023	Sep. 26, 2023	Aug. 31, 2023
Business Acquisition [Line Items]
Goodwill			$ 655			$ 655			$ 621
Gain from the divestiture of businesses			$ 0		$ 0	944	$ 0
Trade Names
Business Acquisition [Line Items]
Indefinite-lived intangible asset				$ 51
Estimated useful life				2 years
Held for sale \| Product Manufacturing Business
Business Acquisition [Line Items]
Consideration for the sale of a business								$ 2,200
Derecognized net assets	$ 1,200
Gain from the divestiture of businesses	$ 944					944
Transaction, exit and disposal costs						$ 64
ProcureAbility Inc.
Business Acquisition [Line Items]
Amount of cash paid for business acquisitions		$ 60
Assets acquired		87
Intangible assets		40
Goodwill		38
Liabilities assumed		$ 26

Fair Value Measurements - Fair Value Measurements on a Recurring Basis (Details) - Recurring - USD ($) $ in Millions	May 31, 2024	Aug. 31, 2023
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash equivalents	$ 393	$ 0
Short-term investments	26	25
Level 2 \| Designated as hedging instruments \| Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	9	4
Derivative liability	6	17
Level 2 \| Designated as hedging instruments \| Net investment hedges
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	8	9
Derivative liability	1	1
Level 2 \| Not designated as hedging instruments \| Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	14	20
Derivative liability	$ 12	$ 64

Fair Value Measurements - Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	May 31, 2024	Aug. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	$ 2,879	$ 2,875
Senior Notes \| 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	3.95%
Carrying Amount	$ 498	497
Senior Notes \| 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	3.60%
Carrying Amount	$ 497	496
Senior Notes \| 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	3.00%
Carrying Amount	$ 594	593
Senior Notes \| 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	1.70%
Carrying Amount	$ 498	498
Senior Notes \| 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	4.25%
Carrying Amount	$ 496	495
Senior Notes \| 5.450% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate	5.45%
Carrying Amount	$ 296	296
Senior Notes \| Carrying Amount \| Level 2 \| 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	498	497
Senior Notes \| Carrying Amount \| Level 2 \| 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	497	496
Senior Notes \| Carrying Amount \| Level 2 \| 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	594	593
Senior Notes \| Carrying Amount \| Level 2 \| 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	498	498
Senior Notes \| Carrying Amount \| Level 2 \| 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	496	495
Senior Notes \| Carrying Amount \| Level 2 \| 5.450% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying Amount	296	296
Senior Notes \| Fair Value \| Level 2 \| 3.950% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	473	468
Senior Notes \| Fair Value \| Level 2 \| 3.600% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	448	448
Senior Notes \| Fair Value \| Level 2 \| 3.000% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	510	502
Senior Notes \| Fair Value \| Level 2 \| 1.700% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	465	452
Senior Notes \| Fair Value \| Level 2 \| 4.250% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	482	478
Senior Notes \| Fair Value \| Level 2 \| 5.450% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	$ 299	$ 297

Jabil (NYSE:JBL)
Historical Stock Chart
From Jun 2024 to Jul 2024

Jabil (NYSE:JBL)
Historical Stock Chart
From Jul 2023 to Jul 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

JBL Jabil Inc

Jabil Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

JBL Jabil Inc

Jabil Inc News

Your Recent History

Company

Business

Popular

Get The App